BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1457410 CC(C)(C)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C21H22ClFN6O3S/c1-21(2,3)29-26-19(25-27-29)14-8-17-18(9-15(14)23)33(31,32)11-16(24)20(30)28(17)10-12-4-6-13(22)7-5-12/h4-9,16H,10-11,24H2,1-3H3 GBBBTFQHWNQAIB-UHFFFAOYSA-N 703773 (3R)-3-amino-7-(2-tert-butyltetrazol-5-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 8 Diacylglycerol kinase alpha Homo sapiens 284 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703773&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274417 507747722 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457411 CC(C)(C)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C21H22ClFN6O3S/c1-21(2,3)29-26-19(25-27-29)14-8-17-18(9-15(14)23)33(31,32)11-16(24)20(30)28(17)10-12-4-6-13(22)7-5-12/h4-9,16H,10-11,24H2,1-3H3 GBBBTFQHWNQAIB-UHFFFAOYSA-N 703773 (3R)-3-amino-7-(2-tert-butyltetrazol-5-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 8 Diacylglycerol kinase zeta Homo sapiens 224 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703773&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274417 507747722 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457412 CC(C)(CO)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C21H22ClFN6O4S/c1-21(2,11-30)29-26-19(25-27-29)14-7-17-18(8-15(14)23)34(32,33)10-16(24)20(31)28(17)9-12-3-5-13(22)6-4-12/h3-8,16,30H,9-11,24H2,1-2H3 ODFZMFZLVFYWGF-UHFFFAOYSA-N 703774 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[2-(2-hydroxy-2-methyl-propyl)tetrazol-5-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one and (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[2-(2-hydroxy-1,1-dimethyl-ethyl)tetrazol-5-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 28 Diacylglycerol kinase alpha Homo sapiens 513 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703774&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873839 507747723 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457413 CC(C)(CO)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C21H22ClFN6O4S/c1-21(2,11-30)29-26-19(25-27-29)14-7-17-18(8-15(14)23)34(32,33)10-16(24)20(31)28(17)9-12-3-5-13(22)6-4-12/h3-8,16,30H,9-11,24H2,1-2H3 ODFZMFZLVFYWGF-UHFFFAOYSA-N 703774 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[2-(2-hydroxy-2-methyl-propyl)tetrazol-5-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one and (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[2-(2-hydroxy-1,1-dimethyl-ethyl)tetrazol-5-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 28 Diacylglycerol kinase zeta Homo sapiens 672 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703774&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873839 507747723 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457414 CC(C)(C)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](NC(=O)CN)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C23H25ClFN7O4S/c1-23(2,3)32-29-21(28-30-32)15-8-18-19(9-16(15)25)37(35,36)12-17(27-20(33)10-26)22(34)31(18)11-13-4-6-14(24)7-5-13/h4-9,17H,10-12,26H2,1-3H3,(H,27,33) KQGUFZDOULKJKD-UHFFFAOYSA-N 703775 2-amino-N-[(3R)-7-(2-tert-butyltetrazol-5-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3-dihydro-1lambda6,5-benzothiazepin-3-yl]acetamide::US20240368150, Example 29 Diacylglycerol kinase alpha Homo sapiens >62500 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703775&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873788 507747724 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457415 CC(C)(C)n1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](NC(=O)CN)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C23H25ClFN7O4S/c1-23(2,3)32-29-21(28-30-32)15-8-18-19(9-16(15)25)37(35,36)12-17(27-20(33)10-26)22(34)31(18)11-13-4-6-14(24)7-5-13/h4-9,17H,10-12,26H2,1-3H3,(H,27,33) KQGUFZDOULKJKD-UHFFFAOYSA-N 703775 2-amino-N-[(3R)-7-(2-tert-butyltetrazol-5-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1,4-trioxo-2,3-dihydro-1lambda6,5-benzothiazepin-3-yl]acetamide::US20240368150, Example 29 Diacylglycerol kinase zeta Homo sapiens 33089 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703775&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873788 507747724 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457416 CC(C)(C)c1noc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-26-19(32-27-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 FORILZOITBZJGC-UHFFFAOYSA-N 703776 (3R)-3-Amino-7-(3- tert-butyl-1,2,4- oxadiazol-5-yl)-5-[(4- chlorophenyl)methyl]- 8-fluoro-1,1-dioxo- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 43 Diacylglycerol kinase alpha Homo sapiens 275 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703776&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274328 507747725 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457417 CC(C)(C)c1noc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)n1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-26-19(32-27-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 FORILZOITBZJGC-UHFFFAOYSA-N 703776 (3R)-3-Amino-7-(3- tert-butyl-1,2,4- oxadiazol-5-yl)-5-[(4- chlorophenyl)methyl]- 8-fluoro-1,1-dioxo- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 43 Diacylglycerol kinase zeta Homo sapiens 344 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703776&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274328 507747725 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457418 CC(C)(F)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C21H19ClF2N4O4S/c1-21(2,24)20-26-18(27-32-20)13-7-16-17(8-14(13)23)33(30,31)10-15(25)19(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,25H2,1-2H3 QCZDKWSQPJWJFE-UHFFFAOYSA-N 703777 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(1-fluoro-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 47 Diacylglycerol kinase alpha Homo sapiens 943 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703777&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874178 507747726 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457419 CC(C)(F)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C21H19ClF2N4O4S/c1-21(2,24)20-26-18(27-32-20)13-7-16-17(8-14(13)23)33(30,31)10-15(25)19(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,25H2,1-2H3 QCZDKWSQPJWJFE-UHFFFAOYSA-N 703777 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(1-fluoro-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 47 Diacylglycerol kinase zeta Homo sapiens 62.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703777&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874178 507747726 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457420 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(C(N)C(F)(F)F)n4)cc32)cc1 InChI=1S/C23H23F4N5O5S/c1-11(2)36-13-5-3-12(4-6-13)9-32-17-7-14(20-30-21(37-31-20)19(29)23(25,26)27)15(24)8-18(17)38(34,35)10-16(28)22(32)33/h3-8,11,16,19H,9-10,28-29H2,1-2H3 SWOFOOZAFQLOKF-UHFFFAOYSA-N 703778 (3R)-3-amino-7-[5-(1-amino-2,2,2-trifluoro-ethyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-5-[(4-isopropoxyphenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 48 Diacylglycerol kinase alpha Homo sapiens 403 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703778&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274455 507747727 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457421 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(C(N)C(F)(F)F)n4)cc32)cc1 InChI=1S/C23H23F4N5O5S/c1-11(2)36-13-5-3-12(4-6-13)9-32-17-7-14(20-30-21(37-31-20)19(29)23(25,26)27)15(24)8-18(17)38(34,35)10-16(28)22(32)33/h3-8,11,16,19H,9-10,28-29H2,1-2H3 SWOFOOZAFQLOKF-UHFFFAOYSA-N 703778 (3R)-3-amino-7-[5-(1-amino-2,2,2-trifluoro-ethyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-5-[(4-isopropoxyphenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 48 Diacylglycerol kinase zeta Homo sapiens 114 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703778&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274455 507747727 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457422 CC(C)(C)c1nnc(-c2cc3c(cc2F)SC[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O3S/c1-22(2,3)21-30-29-19(33-21)14-8-17-18(9-15(14)24)35-11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)34-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 PWEWNCFAEZWMDT-UHFFFAOYSA-N 703779 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-4-one::US20240368150, Example 54 Diacylglycerol kinase alpha Homo sapiens 1993 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703779&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874361 507747728 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457423 CC(C)(C)c1nnc(-c2cc3c(cc2F)SC[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O3S/c1-22(2,3)21-30-29-19(33-21)14-8-17-18(9-15(14)24)35-11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)34-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 PWEWNCFAEZWMDT-UHFFFAOYSA-N 703779 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1,5-benzothiazepin-4-one::US20240368150, Example 54 Diacylglycerol kinase zeta Homo sapiens 4093 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703779&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874361 507747728 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457424 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O5S/c1-22(2,3)21-30-29-19(35-21)14-8-17-18(9-15(14)24)37(33,34)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VFIWOJLYCWLKKM-UHFFFAOYSA-N 703780 (3R)-3-Amino-7-(5-tert-butyl- 1,3,4-oxadiazol-2-yl)-8-fluoro- 1,1-dioxo-5-[[4- (trifluoromethoxy)phenyl]methyl]- 2,3-dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 57 Diacylglycerol kinase alpha Homo sapiens 210 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703780&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274354 507747729 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457425 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O5S/c1-22(2,3)21-30-29-19(35-21)14-8-17-18(9-15(14)24)37(33,34)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VFIWOJLYCWLKKM-UHFFFAOYSA-N 703780 (3R)-3-Amino-7-(5-tert-butyl- 1,3,4-oxadiazol-2-yl)-8-fluoro- 1,1-dioxo-5-[[4- (trifluoromethoxy)phenyl]methyl]- 2,3-dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 57 Diacylglycerol kinase zeta Homo sapiens 254 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703780&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274354 507747729 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457426 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O4S/c1-22(2,3)21-30-29-19(34-21)14-8-17-18(9-15(14)24)36(33)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)35-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VVCQPIKPJDMZLC-UHFFFAOYSA-N 703781 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-oxo-5-[[14-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimers 1:1)::US20240368150, Example 62 Diacylglycerol kinase alpha Homo sapiens 452 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703781&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873827 507747730 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457427 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O4S/c1-22(2,3)21-30-29-19(34-21)14-8-17-18(9-15(14)24)36(33)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)35-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VVCQPIKPJDMZLC-UHFFFAOYSA-N 703781 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-oxo-5-[[14-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimers 1:1)::US20240368150, Example 62 Diacylglycerol kinase zeta Homo sapiens 622 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703781&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873827 507747730 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457428 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-27-26-19(32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 KCGBOCHOBRAFDS-UHFFFAOYSA-N 703782 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 63 Diacylglycerol kinase alpha Homo sapiens 200 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703782 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703782&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874037 507747731 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457429 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-27-26-19(32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 KCGBOCHOBRAFDS-UHFFFAOYSA-N 703782 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 63 Diacylglycerol kinase zeta Homo sapiens 126 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703782 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703782&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874037 507747731 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457430 CC(C)(CO)C1=NNC(c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)O1 InChI=1S/C22H24ClFN4O5S/c1-22(2,11-29)21-27-26-19(33-21)14-7-17-18(8-15(14)24)34(31,32)10-16(25)20(30)28(17)9-12-3-5-13(23)6-4-12/h3-8,16,19,26,29H,9-11,25H2,1-2H3 HNVOVAVNFACAKC-UHFFFAOYSA-N 703783 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-hydroxy-1,1- dimethyl-ethyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one (**)::US20240368150, Example 86 Diacylglycerol kinase alpha Homo sapiens 643 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703783&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 172879043 507747732 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457431 CC(C)(CO)C1=NNC(c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)O1 InChI=1S/C22H24ClFN4O5S/c1-22(2,11-29)21-27-26-19(33-21)14-7-17-18(8-15(14)24)34(31,32)10-16(25)20(30)28(17)9-12-3-5-13(23)6-4-12/h3-8,16,19,26,29H,9-11,25H2,1-2H3 HNVOVAVNFACAKC-UHFFFAOYSA-N 703783 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-hydroxy-1,1- dimethyl-ethyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one (**)::US20240368150, Example 86 Diacylglycerol kinase zeta Homo sapiens 685 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703783&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 172879043 507747732 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457432 CN(C)C(=O)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C21H19ClFN5O5S/c1-27(2)21(30)19-26-25-18(33-19)13-7-16-17(8-14(13)23)34(31,32)10-15(24)20(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,24H2,1-2H3 LYNQDQBEGXICGD-UHFFFAOYSA-N 703784 N,N-dimethyl-5-[(3R)-3- amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-1,3,4-oxadiazole-2- carboxamide (*****)::US20240368150, Example 87 Diacylglycerol kinase alpha Homo sapiens 3060 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703784&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573560 507747733 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457433 CN(C)C(=O)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C21H19ClFN5O5S/c1-27(2)21(30)19-26-25-18(33-19)13-7-16-17(8-14(13)23)34(31,32)10-15(24)20(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,24H2,1-2H3 LYNQDQBEGXICGD-UHFFFAOYSA-N 703784 N,N-dimethyl-5-[(3R)-3- amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-1,3,4-oxadiazole-2- carboxamide (*****)::US20240368150, Example 87 Diacylglycerol kinase zeta Homo sapiens 3666 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703784&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573560 507747733 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457434 CC(C)(C)NC(=O)c4nnc(c1cc2c(cc1F)S(=O)(=O)C[C@H](N)C(=O)N2Cc3ccc(Cl)cc3)o4 InChI=1S/C23H23ClFN5O5S/c1-23(2,3)27-19(31)21-29-28-20(35-21)14-8-17-18(9-15(14)25)36(33,34)11-16(26)22(32)30(17)10-12-4-6-13(24)7-5-12/h4-9,16H,10-11,26H2,1-3H3,(H,27,31) XWEWBPAUEKZLNS-UHFFFAOYSA-N 703785 N-tert-butyl-5-[(3R)-3-amino- 5-[(4-chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-1,3,4-oxadiazole-2- carboxamide (*****)::US20240368150, Example 90 Diacylglycerol kinase alpha Homo sapiens 2977 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703785&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573595 507747734 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457435 CC(C)(C)NC(=O)c4nnc(c1cc2c(cc1F)S(=O)(=O)C[C@H](N)C(=O)N2Cc3ccc(Cl)cc3)o4 InChI=1S/C23H23ClFN5O5S/c1-23(2,3)27-19(31)21-29-28-20(35-21)14-8-17-18(9-15(14)25)36(33,34)11-16(26)22(32)30(17)10-12-4-6-13(24)7-5-12/h4-9,16H,10-11,26H2,1-3H3,(H,27,31) XWEWBPAUEKZLNS-UHFFFAOYSA-N 703785 N-tert-butyl-5-[(3R)-3-amino- 5-[(4-chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-1,3,4-oxadiazole-2- carboxamide (*****)::US20240368150, Example 90 Diacylglycerol kinase zeta Homo sapiens 4459 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703785&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573595 507747734 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457436 COC(=O)N1CC2CC(c3nnc(-c4cc5c(cc4F)S(=O)(=O)C[C@H](N)C(=O)N5Cc4ccc(Cl)cc4)o3)(C2)C1 InChI=1S/C26H25ClFN5O6S/c1-38-25(35)32-10-15-8-26(9-15,13-32)24-31-30-22(39-24)17-6-20-21(7-18(17)28)40(36,37)12-19(29)23(34)33(20)11-14-2-4-16(27)5-3-14/h2-7,15,19H,8-13,29H2,1H3 JALLRDCKJHNJEL-UHFFFAOYSA-N 703786 methyl 1-[5-[(3R)-3- amino-5-[(4-chloro- phenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1λ6,5-benzo- thiazepin-7-yl]-1,3,4- oxadiazol-2-yl]-3- azabicyclo[3.1.1]- heptane-3-carboxylate::US20240368150, Example 184 Diacylglycerol kinase alpha Homo sapiens 244 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703786&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874580 507747735 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457437 COC(=O)N1CC2CC(c3nnc(-c4cc5c(cc4F)S(=O)(=O)C[C@H](N)C(=O)N5Cc4ccc(Cl)cc4)o3)(C2)C1 InChI=1S/C26H25ClFN5O6S/c1-38-25(35)32-10-15-8-26(9-15,13-32)24-31-30-22(39-24)17-6-20-21(7-18(17)28)40(36,37)12-19(29)23(34)33(20)11-14-2-4-16(27)5-3-14/h2-7,15,19H,8-13,29H2,1H3 JALLRDCKJHNJEL-UHFFFAOYSA-N 703786 methyl 1-[5-[(3R)-3- amino-5-[(4-chloro- phenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1λ6,5-benzo- thiazepin-7-yl]-1,3,4- oxadiazol-2-yl]-3- azabicyclo[3.1.1]- heptane-3-carboxylate::US20240368150, Example 184 Diacylglycerol kinase zeta Homo sapiens 290 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703786&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874580 507747735 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457438 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(N4CCOCC4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O5S/c23-14-3-1-13(2-4-14)11-29-18-9-15(20-26-22(34-27-20)28-5-7-33-8-6-28)16(24)10-19(18)35(31,32)12-17(25)21(29)30/h1-4,9-10,17H,5-8,11-12,25H2 JKDQDURECMHXQY-UHFFFAOYSA-N 703787 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8-fluoro- 7-(5-morpholino- 1,2,4-oxadiazol- 3-yl)-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 196 Diacylglycerol kinase alpha Homo sapiens 216 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703787&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774027 507747736 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457439 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(N4CCOCC4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O5S/c23-14-3-1-13(2-4-14)11-29-18-9-15(20-26-22(34-27-20)28-5-7-33-8-6-28)16(24)10-19(18)35(31,32)12-17(25)21(29)30/h1-4,9-10,17H,5-8,11-12,25H2 JKDQDURECMHXQY-UHFFFAOYSA-N 703787 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8-fluoro- 7-(5-morpholino- 1,2,4-oxadiazol- 3-yl)-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 196 Diacylglycerol kinase zeta Homo sapiens 231 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703787&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774027 507747736 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457440 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(N4CCOC(F)(F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H19ClF3N5O5S/c23-13-3-1-12(2-4-13)9-31-17-7-14(15(24)8-18(17)37(33,34)10-16(27)20(31)32)19-28-21(36-29-19)30-5-6-35-22(25,26)11-30/h1-4,7-8,16H,5-6,9-11,27H2 YOXRYTKRGNEZPF-UHFFFAOYSA-N 703788 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2,2- difluoromorpholin-4-yl)-1,2,4- oxadiazol-3-yl]-8-fluoro-1, 1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 204 Diacylglycerol kinase alpha Homo sapiens 68.0 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703788&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573512 507747737 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457441 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(N4CCOC(F)(F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H19ClF3N5O5S/c23-13-3-1-12(2-4-13)9-31-17-7-14(15(24)8-18(17)37(33,34)10-16(27)20(31)32)19-28-21(36-29-19)30-5-6-35-22(25,26)11-30/h1-4,7-8,16H,5-6,9-11,27H2 YOXRYTKRGNEZPF-UHFFFAOYSA-N 703788 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2,2- difluoromorpholin-4-yl)-1,2,4- oxadiazol-3-yl]-8-fluoro-1, 1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 204 Diacylglycerol kinase zeta Homo sapiens 70.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703788&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573512 507747737 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457442 CC1(C)CN(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)CCO1 InChI=1S/C24H25ClFN5O5S/c1-24(2)13-30(7-8-35-24)23-28-21(29-36-23)16-9-19-20(10-17(16)26)37(33,34)12-18(27)22(32)31(19)11-14-3-5-15(25)6-4-14/h3-6,9-10,18H,7-8,11-13,27H2,1-2H3 DPJDKMFUEIFBHY-UHFFFAOYSA-N 703789 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (2,2-dimethylmorpholin-4-yl)- 1,2,4-oxadiazol-3-yl]-8-fluoro- 1,1-dioxo-2,3-dihydro-16,5- benzothiazepin-4-one::US20240368150, Example 205 Diacylglycerol kinase alpha Homo sapiens 299 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703789&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573510 507747738 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457443 CC1(C)CN(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)CCO1 InChI=1S/C24H25ClFN5O5S/c1-24(2)13-30(7-8-35-24)23-28-21(29-36-23)16-9-19-20(10-17(16)26)37(33,34)12-18(27)22(32)31(19)11-14-3-5-15(25)6-4-14/h3-6,9-10,18H,7-8,11-13,27H2,1-2H3 DPJDKMFUEIFBHY-UHFFFAOYSA-N 703789 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (2,2-dimethylmorpholin-4-yl)- 1,2,4-oxadiazol-3-yl]-8-fluoro- 1,1-dioxo-2,3-dihydro-16,5- benzothiazepin-4-one::US20240368150, Example 205 Diacylglycerol kinase zeta Homo sapiens 147 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703789&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573510 507747738 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457444 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5CC54)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClFN5O4S/c24-13-3-1-12(2-4-13)10-30-18-7-14(15(25)8-20(18)35(32)11-16(26)22(30)31)21-27-23(34-28-21)29-5-6-33-19-9-17(19)29/h1-4,7-8,16-17,19H,5-6,9-11,26H2 NWTYKFQHIZEKEK-UHFFFAOYSA-N 703790 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(2-oxa-5-azabicyclo[4.1.0]heptan-5-yl)-1,2,4-oxadiazol-3-yl]-1-oxo-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimer A)::US20240368150, Example 207 Diacylglycerol kinase alpha Homo sapiens >62500 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703790&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874282 507747739 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457445 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5CC54)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClFN5O4S/c24-13-3-1-12(2-4-13)10-30-18-7-14(15(25)8-20(18)35(32)11-16(26)22(30)31)21-27-23(34-28-21)29-5-6-33-19-9-17(19)29/h1-4,7-8,16-17,19H,5-6,9-11,26H2 NWTYKFQHIZEKEK-UHFFFAOYSA-N 703790 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(2-oxa-5-azabicyclo[4.1.0]heptan-5-yl)-1,2,4-oxadiazol-3-yl]-1-oxo-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimer A)::US20240368150, Example 207 Diacylglycerol kinase zeta Homo sapiens 193 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703790&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874282 507747739 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457446 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5CC54)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClFN5O4S/c24-13-3-1-12(2-4-13)10-30-18-7-14(15(25)8-20(18)35(32)11-16(26)22(30)31)21-27-23(34-28-21)29-5-6-33-19-9-17(19)29/h1-4,7-8,16-17,19H,5-6,9-11,26H2 NWTYKFQHIZEKEK-UHFFFAOYSA-N 703791 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-oxa-5- azabicyclo[4.1.0]heptan-5-yl)- 1,2,4-oxadiazol-3-yl]-1-oxo- 2,3-dihydro-1lambda4,5- benzothiazepin-4-one (Epimer B) (*)::US20240368150, Example 208 Diacylglycerol kinase alpha Homo sapiens 2641 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703791&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874282 507747740 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457447 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5CC54)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClFN5O4S/c24-13-3-1-12(2-4-13)10-30-18-7-14(15(25)8-20(18)35(32)11-16(26)22(30)31)21-27-23(34-28-21)29-5-6-33-19-9-17(19)29/h1-4,7-8,16-17,19H,5-6,9-11,26H2 NWTYKFQHIZEKEK-UHFFFAOYSA-N 703791 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-oxa-5- azabicyclo[4.1.0]heptan-5-yl)- 1,2,4-oxadiazol-3-yl]-1-oxo- 2,3-dihydro-1lambda4,5- benzothiazepin-4-one (Epimer B) (*)::US20240368150, Example 208 Diacylglycerol kinase zeta Homo sapiens 147 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703791&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874282 507747740 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457448 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOCC4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O4S/c23-14-3-1-13(2-4-14)11-29-18-9-15(16(24)10-19(18)34(31)12-17(25)21(29)30)20-26-22(33-27-20)28-5-7-32-8-6-28/h1-4,9-10,17H,5-8,11-12,25H2 FCCQZVSEZYKBOO-UHFFFAOYSA-N 703792 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-(5-morpholino-1,2,4- oxadiazol-3-yl)-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 209 Diacylglycerol kinase alpha Homo sapiens 1487 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703792&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874124 507747741 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457449 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOCC4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O4S/c23-14-3-1-13(2-4-14)11-29-18-9-15(16(24)10-19(18)34(31)12-17(25)21(29)30)20-26-22(33-27-20)28-5-7-32-8-6-28/h1-4,9-10,17H,5-8,11-12,25H2 FCCQZVSEZYKBOO-UHFFFAOYSA-N 703792 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-(5-morpholino-1,2,4- oxadiazol-3-yl)-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 209 Diacylglycerol kinase zeta Homo sapiens 408 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703792&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874124 507747741 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457450 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5(CC5)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClFN5O4S/c25-15-3-1-14(2-4-15)11-31-19-9-16(17(26)10-20(19)36(33)12-18(27)22(31)32)21-28-23(35-29-21)30-7-8-34-24(13-30)5-6-24/h1-4,9-10,18H,5-8,11-13,27H2 OGMRJLKQCVITHH-UHFFFAOYSA-N 703793 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(4-oxa-7- azaspiro[2.5]octan-7-yl)-1,2,4- oxadiazol-3-yl]-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer B) (*)::US20240368150, Example 210 Diacylglycerol kinase alpha Homo sapiens 1619 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703793&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573553 507747742 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457451 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5(CC5)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClFN5O4S/c25-15-3-1-14(2-4-15)11-31-19-9-16(17(26)10-20(19)36(33)12-18(27)22(31)32)21-28-23(35-29-21)30-7-8-34-24(13-30)5-6-24/h1-4,9-10,18H,5-8,11-13,27H2 OGMRJLKQCVITHH-UHFFFAOYSA-N 703793 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(4-oxa-7- azaspiro[2.5]octan-7-yl)-1,2,4- oxadiazol-3-yl]-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer B) (*)::US20240368150, Example 210 Diacylglycerol kinase zeta Homo sapiens 360 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703793&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573553 507747742 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457452 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5(CC5)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClFN5O4S/c25-15-3-1-14(2-4-15)11-31-19-9-16(17(26)10-20(19)36(33)12-18(27)22(31)32)21-28-23(35-29-21)30-7-8-34-24(13-30)5-6-24/h1-4,9-10,18H,5-8,11-13,27H2 OGMRJLKQCVITHH-UHFFFAOYSA-N 703794 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(4-oxa-7- azaspiro[2.5]octan-7-yl)-1,2,4- oxadiazol-3-yl]-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 211 Diacylglycerol kinase alpha Homo sapiens 1290 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703794&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573553 507747743 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457453 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC5(CC5)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClFN5O4S/c25-15-3-1-14(2-4-15)11-31-19-9-16(17(26)10-20(19)36(33)12-18(27)22(31)32)21-28-23(35-29-21)30-7-8-34-24(13-30)5-6-24/h1-4,9-10,18H,5-8,11-13,27H2 OGMRJLKQCVITHH-UHFFFAOYSA-N 703794 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(4-oxa-7- azaspiro[2.5]octan-7-yl)-1,2,4- oxadiazol-3-yl]-1-oxo-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 211 Diacylglycerol kinase zeta Homo sapiens 330 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703794&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573553 507747743 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457454 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC(C(F)(F)F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20ClF4N5O4S/c24-13-3-1-12(2-4-13)9-33-17-7-14(15(25)8-18(17)38(35)11-16(29)21(33)34)20-30-22(37-31-20)32-5-6-36-19(10-32)23(26,27)28/h1-4,7-8,16,19H,5-6,9-11,29H2 BOZKDCCZDWHHLC-UHFFFAOYSA-N 703795 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1-oxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer B) (*)::US20240368150, Example 212 Diacylglycerol kinase alpha Homo sapiens 975 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703795&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573574 507747744 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457455 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC(C(F)(F)F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20ClF4N5O4S/c24-13-3-1-12(2-4-13)9-33-17-7-14(15(25)8-18(17)38(35)11-16(29)21(33)34)20-30-22(37-31-20)32-5-6-36-19(10-32)23(26,27)28/h1-4,7-8,16,19H,5-6,9-11,29H2 BOZKDCCZDWHHLC-UHFFFAOYSA-N 703795 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1-oxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer B) (*)::US20240368150, Example 212 Diacylglycerol kinase zeta Homo sapiens 46.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703795&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573574 507747744 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457456 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC(C(F)(F)F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20ClF4N5O4S/c24-13-3-1-12(2-4-13)9-33-17-7-14(15(25)8-18(17)38(35)11-16(29)21(33)34)20-30-22(37-31-20)32-5-6-36-19(10-32)23(26,27)28/h1-4,7-8,16,19H,5-6,9-11,29H2 BOZKDCCZDWHHLC-UHFFFAOYSA-N 703796 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1-oxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 213 Diacylglycerol kinase alpha Homo sapiens 2136 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703796&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573574 507747745 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457457 N[C@H]1CS(=O)c2cc(F)c(-c3noc(N4CCOC(C(F)(F)F)C4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20ClF4N5O4S/c24-13-3-1-12(2-4-13)9-33-17-7-14(15(25)8-18(17)38(35)11-16(29)21(33)34)20-30-22(37-31-20)32-5-6-36-19(10-32)23(26,27)28/h1-4,7-8,16,19H,5-6,9-11,29H2 BOZKDCCZDWHHLC-UHFFFAOYSA-N 703796 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1-oxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda4,5-benzothiazepin- 4-one (Epimer A) (*)::US20240368150, Example 213 Diacylglycerol kinase zeta Homo sapiens 52.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703796&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573574 507747745 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457458 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(N5CCOC6(CC6)C5)n4)cc32)cn1 InChI=1S/C26H29FN6O6S/c1-15(2)38-22-4-3-16(11-29-22)12-33-20-9-17(18(27)10-21(20)40(35,36)13-19(28)24(33)34)23-30-25(39-31-23)32-7-8-37-26(14-32)5-6-26/h3-4,9-11,15,19H,5-8,12-14,28H2,1-2H3 VQLZPRIOYAXFKE-UHFFFAOYSA-N 703797 (3R)-3-amino-8-fluoro-5-[(6-isopropoxy-3-pyridyl)methyl]-7-[5-(4-oxa-7-azaspiro[2.5]octan-7-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 214 Diacylglycerol kinase alpha Homo sapiens 214 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703797&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874006 507747746 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457459 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(N5CCOC6(CC6)C5)n4)cc32)cn1 InChI=1S/C26H29FN6O6S/c1-15(2)38-22-4-3-16(11-29-22)12-33-20-9-17(18(27)10-21(20)40(35,36)13-19(28)24(33)34)23-30-25(39-31-23)32-7-8-37-26(14-32)5-6-26/h3-4,9-11,15,19H,5-8,12-14,28H2,1-2H3 VQLZPRIOYAXFKE-UHFFFAOYSA-N 703797 (3R)-3-amino-8-fluoro-5-[(6-isopropoxy-3-pyridyl)methyl]-7-[5-(4-oxa-7-azaspiro[2.5]octan-7-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 214 Diacylglycerol kinase zeta Homo sapiens 100.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703797&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874006 507747746 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457460 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(N5CCOC6(CC6)C5)n4)cc32)nc1 InChI=1S/C26H29FN6O6S/c1-15(2)38-17-4-3-16(29-11-17)12-33-21-9-18(19(27)10-22(21)40(35,36)13-20(28)24(33)34)23-30-25(39-31-23)32-7-8-37-26(14-32)5-6-26/h3-4,9-11,15,20H,5-8,12-14,28H2,1-2H3 RCKQHWTUUHHAKQ-UHFFFAOYSA-N 703798 (3R)-3-amino-8-fluoro-5-[(5-isopropoxy-2-pyridyl)methyl]-7-[5-(4-oxa-7-azaspiro[2.5]octan-7-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 215 Diacylglycerol kinase alpha Homo sapiens 662 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703798&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873845 507747747 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457461 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(N5CCOC6(CC6)C5)n4)cc32)nc1 InChI=1S/C26H29FN6O6S/c1-15(2)38-17-4-3-16(29-11-17)12-33-21-9-18(19(27)10-22(21)40(35,36)13-20(28)24(33)34)23-30-25(39-31-23)32-7-8-37-26(14-32)5-6-26/h3-4,9-11,15,20H,5-8,12-14,28H2,1-2H3 RCKQHWTUUHHAKQ-UHFFFAOYSA-N 703798 (3R)-3-amino-8-fluoro-5-[(5-isopropoxy-2-pyridyl)methyl]-7-[5-(4-oxa-7-azaspiro[2.5]octan-7-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 215 Diacylglycerol kinase zeta Homo sapiens 886 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703798&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873845 507747747 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457462 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(C(C)(C)C#N)cc2)o1 InChI=1S/C26H28FN5O4S/c1-25(2,3)24-31-30-22(36-24)17-10-20-21(11-18(17)27)37(34,35)13-19(29)23(33)32(20)12-15-6-8-16(9-7-15)26(4,5)14-28/h6-11,19H,12-13,29H2,1-5H3 XYJWTFYNEPAGAC-UHFFFAOYSA-N 703799 2-methyl-2-[4-[[(3R)-3-amino- 7-(5-tert-butyl-1,3,4- oxadiazol-2-yl)-8-fluoro-1,1,4- trioxo-2,3-dihydro-1lambda6,5- benzothiazepin-5- yl]methyl]phenyl] propanenitrile::US20240368150, Example 244 Diacylglycerol kinase alpha Homo sapiens 836 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703799&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573601 507747748 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457463 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(C(C)(C)C#N)cc2)o1 InChI=1S/C26H28FN5O4S/c1-25(2,3)24-31-30-22(36-24)17-10-20-21(11-18(17)27)37(34,35)13-19(29)23(33)32(20)12-15-6-8-16(9-7-15)26(4,5)14-28/h6-11,19H,12-13,29H2,1-5H3 XYJWTFYNEPAGAC-UHFFFAOYSA-N 703799 2-methyl-2-[4-[[(3R)-3-amino- 7-(5-tert-butyl-1,3,4- oxadiazol-2-yl)-8-fluoro-1,1,4- trioxo-2,3-dihydro-1lambda6,5- benzothiazepin-5- yl]methyl]phenyl] propanenitrile::US20240368150, Example 244 Diacylglycerol kinase zeta Homo sapiens 1101 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703799&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573601 507747748 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457464 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC3CCCC3)cc2)o1 InChI=1S/C27H31FN4O5S/c1-27(2,3)26-31-30-24(37-26)19-12-22-23(13-20(19)28)38(34,35)15-21(29)25(33)32(22)14-16-8-10-18(11-9-16)36-17-6-4-5-7-17/h8-13,17,21H,4-7,14-15,29H2,1-3H3 WYFVMTBLBXBWGY-UHFFFAOYSA-N 703800 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 253 Diacylglycerol kinase alpha Homo sapiens 198 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703800&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873953 507747749 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457465 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC3CCCC3)cc2)o1 InChI=1S/C27H31FN4O5S/c1-27(2,3)26-31-30-24(37-26)19-12-22-23(13-20(19)28)38(34,35)15-21(29)25(33)32(22)14-16-8-10-18(11-9-16)36-17-6-4-5-7-17/h8-13,17,21H,4-7,14-15,29H2,1-3H3 WYFVMTBLBXBWGY-UHFFFAOYSA-N 703800 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 253 Diacylglycerol kinase zeta Homo sapiens 105 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703800&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873953 507747749 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457466 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](NC(=O)CN)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C24H25ClFN5O5S/c1-24(2,3)23-30-29-21(36-23)15-8-18-19(9-16(15)26)37(34,35)12-17(28-20(32)10-27)22(33)31(18)11-13-4-6-14(25)7-5-13/h4-9,17H,10-12,27H2,1-3H3,(H,28,32) YNGNVHXBLXISHD-UHFFFAOYSA-N 703801 2-amino-N-[(3R)-7-(5-tert- butyl-1,3,4-oxadiazol-2-yl)-5- [(4-chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 3-yl]acetamide::US20240368150, Example 266 Diacylglycerol kinase alpha Homo sapiens 54480 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703801&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874531 507747750 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457467 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](NC(=O)CN)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C24H25ClFN5O5S/c1-24(2,3)23-30-29-21(36-23)15-8-18-19(9-16(15)26)37(34,35)12-17(28-20(32)10-27)22(33)31(18)11-13-4-6-14(25)7-5-13/h4-9,17H,10-12,27H2,1-3H3,(H,28,32) YNGNVHXBLXISHD-UHFFFAOYSA-N 703801 2-amino-N-[(3R)-7-(5-tert- butyl-1,3,4-oxadiazol-2-yl)-5- [(4-chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 3-yl]acetamide::US20240368150, Example 266 Diacylglycerol kinase zeta Homo sapiens 40085 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703801&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874531 507747750 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457468 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-26-19(27-32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 KGFNHLFIMHLDBI-UHFFFAOYSA-N 703802 (3R)-3-amino-7-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 289 Diacylglycerol kinase alpha Homo sapiens 587 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703802&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274514 507747751 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457469 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C22H22ClFN4O4S/c1-22(2,3)21-26-19(27-32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 KGFNHLFIMHLDBI-UHFFFAOYSA-N 703802 (3R)-3-amino-7-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-5-[(4-chlorophenyl)methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 289 Diacylglycerol kinase zeta Homo sapiens 482 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703802&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274514 507747751 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457470 COC(F)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1)C(F)(F)F InChI=1S/C21H16ClF5N4O5S/c1-35-20(24,21(25,26)27)19-29-17(30-36-19)12-6-15-16(7-13(12)23)37(33,34)9-14(28)18(32)31(15)8-10-2-4-11(22)5-3-10/h2-7,14H,8-9,28H2,1H3 OOPRSNMZDGSVTG-UHFFFAOYSA-N 703803 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1-dioxo-7-[5-(1,2,2,2- tetrafluoro-1-methoxy-ethyl)- 1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 292 Diacylglycerol kinase alpha Homo sapiens 528 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703803&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573642 507747752 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457471 COC(F)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1)C(F)(F)F InChI=1S/C21H16ClF5N4O5S/c1-35-20(24,21(25,26)27)19-29-17(30-36-19)12-6-15-16(7-13(12)23)37(33,34)9-14(28)18(32)31(15)8-10-2-4-11(22)5-3-10/h2-7,14H,8-9,28H2,1H3 OOPRSNMZDGSVTG-UHFFFAOYSA-N 703803 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1-dioxo-7-[5-(1,2,2,2- tetrafluoro-1-methoxy-ethyl)- 1,2,4-oxadiazol-3-yl]-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 292 Diacylglycerol kinase zeta Homo sapiens 494 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703803&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573642 507747752 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457472 CC(C)(C)NC(=O)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C23H23ClFN5O5S/c1-23(2,3)28-20(31)21-27-19(29-35-21)14-8-17-18(9-15(14)25)36(33,34)11-16(26)22(32)30(17)10-12-4-6-13(24)7-5-12/h4-9,16H,10-11,26H2,1-3H3,(H,28,31) JNOUIYMPEFPKNS-UHFFFAOYSA-N 703804 3-[(3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-N-tert-butyl-1,2,4- oxadiazole-5-carboxamide::US20240368150, Example 293 Diacylglycerol kinase alpha Homo sapiens 1153 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703804&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573639 507747753 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457473 CC(C)(C)NC(=O)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C23H23ClFN5O5S/c1-23(2,3)28-20(31)21-27-19(29-35-21)14-8-17-18(9-15(14)25)36(33,34)11-16(26)22(32)30(17)10-12-4-6-13(24)7-5-12/h4-9,16H,10-11,26H2,1-3H3,(H,28,31) JNOUIYMPEFPKNS-UHFFFAOYSA-N 703804 3-[(3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1,4-trioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 7-yl]-N-tert-butyl-1,2,4- oxadiazole-5-carboxamide::US20240368150, Example 293 Diacylglycerol kinase zeta Homo sapiens 1203 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703804&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573639 507747753 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457474 CC(N)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1)C(F)(F)F InChI=1S/C21H18ClF4N5O4S/c1-20(28,21(24,25)26)19-29-17(30-35-19)12-6-15-16(7-13(12)23)36(33,34)9-14(27)18(32)31(15)8-10-2-4-11(22)5-3-10/h2-7,14H,8-9,27-28H2,1H3 RTYNHSQFMZKOQM-UHFFFAOYSA-N 703805 (3R)-3-amino-7-[5-(1-amino- 2,2,2-trifluoro-1-methyl- ethyl)-1,2,4-oxadiazol-3-yl]-5- [(4-chlorophenyl)methyl]-8- fluoro-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (**)::US20240368150, Example 297 Diacylglycerol kinase alpha Homo sapiens 373 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703805&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573626 507747754 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457475 CC(N)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1)C(F)(F)F InChI=1S/C21H18ClF4N5O4S/c1-20(28,21(24,25)26)19-29-17(30-35-19)12-6-15-16(7-13(12)23)36(33,34)9-14(27)18(32)31(15)8-10-2-4-11(22)5-3-10/h2-7,14H,8-9,27-28H2,1H3 RTYNHSQFMZKOQM-UHFFFAOYSA-N 703805 (3R)-3-amino-7-[5-(1-amino- 2,2,2-trifluoro-1-methyl- ethyl)-1,2,4-oxadiazol-3-yl]-5- [(4-chlorophenyl)methyl]-8- fluoro-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (**)::US20240368150, Example 297 Diacylglycerol kinase zeta Homo sapiens 357 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703805&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573626 507747754 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457476 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(C(N)(c4ccc(F)cc4)C(F)(F)F)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C26H19ClF5N5O4S/c27-15-5-1-13(2-6-15)11-37-20-9-17(18(29)10-21(20)42(39,40)12-19(33)23(37)38)22-35-24(41-36-22)25(34,26(30,31)32)14-3-7-16(28)8-4-14/h1-10,19H,11-12,33-34H2 KUGJFWWOSVNBNN-UHFFFAOYSA-N 703806 (3R)-3-amino-7-[5-[1-amino- 2,2,2-trifluoro-1-(4- fluorophenyl)ethyl]-1,2,4- oxadiazol-3-yl]-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 300 Diacylglycerol kinase alpha Homo sapiens 3935 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703806&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573583 507747755 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457477 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(C(N)(c4ccc(F)cc4)C(F)(F)F)n3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C26H19ClF5N5O4S/c27-15-5-1-13(2-6-15)11-37-20-9-17(18(29)10-21(20)42(39,40)12-19(33)23(37)38)22-35-24(41-36-22)25(34,26(30,31)32)14-3-7-16(28)8-4-14/h1-10,19H,11-12,33-34H2 KUGJFWWOSVNBNN-UHFFFAOYSA-N 703806 (3R)-3-amino-7-[5-[1-amino- 2,2,2-trifluoro-1-(4- fluorophenyl)ethyl]-1,2,4- oxadiazol-3-yl]-5-[(4- chlorophenyl)methyl]-8- fluoro-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 300 Diacylglycerol kinase zeta Homo sapiens 481 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703806&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573583 507747755 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457478 CC(C)(CO)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C22H22ClFN4O5S/c1-22(2,11-29)21-26-19(27-33-21)14-7-17-18(8-15(14)24)34(31,32)10-16(25)20(30)28(17)9-12-3-5-13(23)6-4-12/h3-8,16,29H,9-11,25H2,1-2H3 YBDJMXCVTAFKJD-UHFFFAOYSA-N 703807 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-hydroxy-1,1- dimethyl-ethyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1λ6,5-benzothiazepin- 4-one::US20240368150, Example 303 Diacylglycerol kinase alpha Homo sapiens 301 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703807&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573495 507747756 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457479 CC(C)(CO)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C22H22ClFN4O5S/c1-22(2,11-29)21-26-19(27-33-21)14-7-17-18(8-15(14)24)34(31,32)10-16(25)20(30)28(17)9-12-3-5-13(23)6-4-12/h3-8,16,29H,9-11,25H2,1-2H3 YBDJMXCVTAFKJD-UHFFFAOYSA-N 703807 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-hydroxy-1,1- dimethyl-ethyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1λ6,5-benzothiazepin- 4-one::US20240368150, Example 303 Diacylglycerol kinase zeta Homo sapiens 251 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703807&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573495 507747756 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457480 Cc1ccncc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C24H19ClFN5O4S/c1-13-6-7-28-10-17(13)23-29-22(30-35-23)16-8-20-21(9-18(16)26)36(33,34)12-19(27)24(32)31(20)11-14-2-4-15(25)5-3-14/h2-10,19H,11-12,27H2,1H3 DXRUYSNPWBYORU-UHFFFAOYSA-N 703808 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(4-methyl-3-pyridyl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 310 Diacylglycerol kinase alpha Homo sapiens 2766 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703808&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874068 507747757 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457481 Cc1ccncc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C24H19ClFN5O4S/c1-13-6-7-28-10-17(13)23-29-22(30-35-23)16-8-20-21(9-18(16)26)36(33,34)12-19(27)24(32)31(20)11-14-2-4-15(25)5-3-14/h2-10,19H,11-12,27H2,1H3 DXRUYSNPWBYORU-UHFFFAOYSA-N 703808 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(4-methyl-3-pyridyl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 310 Diacylglycerol kinase zeta Homo sapiens 98.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703808&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874068 507747757 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457482 Cc1ccc(S(C)(=O)=O)cc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C26H22ClFN4O6S2/c1-14-3-8-17(39(2,34)35)9-18(14)25-30-24(31-38-25)19-10-22-23(11-20(19)28)40(36,37)13-21(29)26(33)32(22)12-15-4-6-16(27)7-5-15/h3-11,21H,12-13,29H2,1-2H3 YSJYOTKISQEOGV-UHFFFAOYSA-N 703809 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-methyl-5- methylsulfonyl-phenyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (**)::US20240368150, Example 311 Diacylglycerol kinase alpha Homo sapiens 43696 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703809&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774003 507747758 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457483 Cc1ccc(S(C)(=O)=O)cc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C26H22ClFN4O6S2/c1-14-3-8-17(39(2,34)35)9-18(14)25-30-24(31-38-25)19-10-22-23(11-20(19)28)40(36,37)13-21(29)26(33)32(22)12-15-4-6-16(27)7-5-15/h3-11,21H,12-13,29H2,1-2H3 YSJYOTKISQEOGV-UHFFFAOYSA-N 703809 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-methyl-5- methylsulfonyl-phenyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (**)::US20240368150, Example 311 Diacylglycerol kinase zeta Homo sapiens 69.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703809&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774003 507747758 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457484 Cc1nc(F)ccc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C24H18ClF2N5O4S/c1-12-15(6-7-21(27)29-12)23-30-22(31-36-23)16-8-19-20(9-17(16)26)37(34,35)11-18(28)24(33)32(19)10-13-2-4-14(25)5-3-13/h2-9,18H,10-11,28H2,1H3 SJVUQMHQKOWGGQ-UHFFFAOYSA-N 703810 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(6-fluoro-2- methyl-3-pyridyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 312 Diacylglycerol kinase alpha Homo sapiens 454 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703810&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573637 507747759 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457485 Cc1nc(F)ccc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C24H18ClF2N5O4S/c1-12-15(6-7-21(27)29-12)23-30-22(31-36-23)16-8-19-20(9-17(16)26)37(34,35)11-18(28)24(33)32(19)10-13-2-4-14(25)5-3-13/h2-9,18H,10-11,28H2,1H3 SJVUQMHQKOWGGQ-UHFFFAOYSA-N 703810 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(6-fluoro-2- methyl-3-pyridyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 312 Diacylglycerol kinase zeta Homo sapiens 29.0 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703810&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573637 507747759 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457486 Cc1cc(C)c(-c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)cn1 InChI=1S/C25H21ClFN5O4S/c1-13-7-14(2)29-10-18(13)24-30-23(31-36-24)17-8-21-22(9-19(17)27)37(34,35)12-20(28)25(33)32(21)11-15-3-5-16(26)6-4-15/h3-10,20H,11-12,28H2,1-2H3 XGCYMCLRGGYAEM-UHFFFAOYSA-N 703811 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (4,6-dimethyl-3-pyridyl)-1,2,4- oxadiazol-3-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 313 Diacylglycerol kinase alpha Homo sapiens 1659 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703811&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573536 507747760 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457487 Cc1cc(C)c(-c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)cn1 InChI=1S/C25H21ClFN5O4S/c1-13-7-14(2)29-10-18(13)24-30-23(31-36-24)17-8-21-22(9-19(17)27)37(34,35)12-20(28)25(33)32(21)11-15-3-5-16(26)6-4-15/h3-10,20H,11-12,28H2,1-2H3 XGCYMCLRGGYAEM-UHFFFAOYSA-N 703811 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (4,6-dimethyl-3-pyridyl)-1,2,4- oxadiazol-3-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 313 Diacylglycerol kinase zeta Homo sapiens 130 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703811&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573536 507747760 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457488 Cc1cc(S(C)(=O)=O)ccc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C26H22ClFN4O6S2/c1-14-9-17(39(2,34)35)7-8-18(14)25-30-24(31-38-25)19-10-22-23(11-20(19)28)40(36,37)13-21(29)26(33)32(22)12-15-3-5-16(27)6-4-15/h3-11,21H,12-13,29H2,1-2H3 NWHCSIONKRWJLE-UHFFFAOYSA-N 703812 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-methyl-4- methylsulfonyl-phenyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1λ6,5-benzothiazepin- 4-one::US20240368150, Example 314 Diacylglycerol kinase alpha Homo sapiens 6146 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703812&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573513 507747761 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457489 Cc1cc(S(C)(=O)=O)ccc1-c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)no1 InChI=1S/C26H22ClFN4O6S2/c1-14-9-17(39(2,34)35)7-8-18(14)25-30-24(31-38-25)19-10-22-23(11-20(19)28)40(36,37)13-21(29)26(33)32(22)12-15-3-5-16(27)6-4-15/h3-11,21H,12-13,29H2,1-2H3 NWHCSIONKRWJLE-UHFFFAOYSA-N 703812 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-8- fluoro-7-[5-(2-methyl-4- methylsulfonyl-phenyl)-1,2,4- oxadiazol-3-yl]-1,1-dioxo-2,3- dihydro-1λ6,5-benzothiazepin- 4-one::US20240368150, Example 314 Diacylglycerol kinase zeta Homo sapiens 150 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703812&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573513 507747761 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457490 Cc1nnc(-c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)o1 InChI=1S/C21H16ClFN6O5S/c1-10-26-27-20(33-10)19-25-18(28-34-19)13-6-16-17(7-14(13)23)35(31,32)9-15(24)21(30)29(16)8-11-2-4-12(22)5-3-11/h2-7,15H,8-9,24H2,1H3 MCTUJEVTHGIENG-UHFFFAOYSA-N 703813 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 322 Diacylglycerol kinase alpha Homo sapiens 17831 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703813&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874593 507747762 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457491 Cc1nnc(-c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Cl)cc3)no2)o1 InChI=1S/C21H16ClFN6O5S/c1-10-26-27-20(33-10)19-25-18(28-34-19)13-6-16-17(7-14(13)23)35(31,32)9-15(24)21(30)29(16)8-11-2-4-12(22)5-3-11/h2-7,15H,8-9,24H2,1H3 MCTUJEVTHGIENG-UHFFFAOYSA-N 703813 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-8-fluoro-7-[5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,2,4-oxadiazol-3-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 322 Diacylglycerol kinase zeta Homo sapiens 933 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703813&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874593 507747762 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457492 CC(N)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)no1)C(F)(F)F InChI=1S/C22H18F7N5O5S/c1-20(31,21(24,25)26)19-32-17(33-39-19)12-6-15-16(7-13(12)23)40(36,37)9-14(30)18(35)34(15)8-10-2-4-11(5-3-10)38-22(27,28)29/h2-7,14H,8-9,30-31H2,1H3 VPOBYDIVNCVOCA-UHFFFAOYSA-N 703814 (3R)-3-amino-7-[5-(1-amino-2,2,2-trifluoro-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-1,1-dioxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 331 Diacylglycerol kinase alpha Homo sapiens 857 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703814&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874460 507747763 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457493 CC(N)(c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)no1)C(F)(F)F InChI=1S/C22H18F7N5O5S/c1-20(31,21(24,25)26)19-32-17(33-39-19)12-6-15-16(7-13(12)23)40(36,37)9-14(30)18(35)34(15)8-10-2-4-11(5-3-10)38-22(27,28)29/h2-7,14H,8-9,30-31H2,1H3 VPOBYDIVNCVOCA-UHFFFAOYSA-N 703814 (3R)-3-amino-7-[5-(1-amino-2,2,2-trifluoro-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-1,1-dioxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 331 Diacylglycerol kinase zeta Homo sapiens 176 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703814&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874460 507747763 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457494 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(C5CN(C)CC(F)(F)C5)n4)cc32)cc1 InChI=1S/C27H30F3N5O5S/c1-15(2)39-18-6-4-16(5-7-18)11-35-22-8-19(20(28)9-23(22)41(37,38)13-21(31)26(35)36)24-32-25(40-33-24)17-10-27(29,30)14-34(3)12-17/h4-9,15,17,21H,10-14,31H2,1-3H3 VUQAJTLZPYJFCH-UHFFFAOYSA-N 703815 (3R)-3-amino-7-[5-(5,5-difluoro-1-methyl-3-piperidyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-5-[(4-isopropoxyphenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 345 Diacylglycerol kinase alpha Homo sapiens 343 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703815&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874283 507747764 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457495 CC(C)Oc1ccc(CN2C(=O)[C@@H](N)CS(=O)(=O)c3cc(F)c(-c4noc(C5CN(C)CC(F)(F)C5)n4)cc32)cc1 InChI=1S/C27H30F3N5O5S/c1-15(2)39-18-6-4-16(5-7-18)11-35-22-8-19(20(28)9-23(22)41(37,38)13-21(31)26(35)36)24-32-25(40-33-24)17-10-27(29,30)14-34(3)12-17/h4-9,15,17,21H,10-14,31H2,1-3H3 VUQAJTLZPYJFCH-UHFFFAOYSA-N 703815 (3R)-3-amino-7-[5-(5,5-difluoro-1-methyl-3-piperidyl)-1,2,4-oxadiazol-3-yl]-8-fluoro-5-[(4-isopropoxyphenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 345 Diacylglycerol kinase zeta Homo sapiens 207 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703815&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874283 507747764 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457496 COC(=O)N1CCC(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(OC4CCCC4)cc3)no2)C1 InChI=1S/C29H32FN5O7S/c1-40-29(37)34-11-10-18(15-34)27-32-26(33-42-27)21-12-24-25(13-22(21)30)43(38,39)16-23(31)28(36)35(24)14-17-6-8-20(9-7-17)41-19-4-2-3-5-19/h6-9,12-13,18-19,23H,2-5,10-11,14-16,31H2,1H3 UEHRZBBAALJKQU-UHFFFAOYSA-N 703816 methyl 3-[3-[(3R)-3-amino-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1,4-trioxo-2,3-dihydro-1λ6,5-benzothiazepin-7-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboxylate::US20240368150, Example 348 Diacylglycerol kinase alpha Homo sapiens 2662 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703816&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874294 507747765 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457497 COC(=O)N1CCC(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(OC4CCCC4)cc3)no2)C1 InChI=1S/C29H32FN5O7S/c1-40-29(37)34-11-10-18(15-34)27-32-26(33-42-27)21-12-24-25(13-22(21)30)43(38,39)16-23(31)28(36)35(24)14-17-6-8-20(9-7-17)41-19-4-2-3-5-19/h6-9,12-13,18-19,23H,2-5,10-11,14-16,31H2,1H3 UEHRZBBAALJKQU-UHFFFAOYSA-N 703816 methyl 3-[3-[(3R)-3-amino-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1,4-trioxo-2,3-dihydro-1λ6,5-benzothiazepin-7-yl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboxylate::US20240368150, Example 348 Diacylglycerol kinase zeta Homo sapiens 374 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703816&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874294 507747765 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457498 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC3CCCC3)cc2)no1 InChI=1S/C27H31FN4O5S/c1-27(2,3)26-30-24(31-37-26)19-12-22-23(13-20(19)28)38(34,35)15-21(29)25(33)32(22)14-16-8-10-18(11-9-16)36-17-6-4-5-7-17/h8-13,17,21H,4-7,14-15,29H2,1-3H3 LRNBQIYOCMRBAF-UHFFFAOYSA-N 703817 (3R)-3-amino-7-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 350 Diacylglycerol kinase alpha Homo sapiens 1613 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703817&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274440 507747766 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457499 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC3CCCC3)cc2)no1 InChI=1S/C27H31FN4O5S/c1-27(2,3)26-30-24(31-37-26)19-12-22-23(13-20(19)28)38(34,35)15-21(29)25(33)32(22)14-16-8-10-18(11-9-16)36-17-6-4-5-7-17/h8-13,17,21H,4-7,14-15,29H2,1-3H3 LRNBQIYOCMRBAF-UHFFFAOYSA-N 703817 (3R)-3-amino-7-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-5-[[4-(cyclopentoxy)phenyl]methyl]-8-fluoro-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 350 Diacylglycerol kinase zeta Homo sapiens 235 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703817&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274440 507747766 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457500 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(F)cc2)no1 InChI=1S/C22H22F2N4O4S/c1-22(2,3)21-26-19(27-32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 ZNXOUIHRDAABGR-UHFFFAOYSA-N 703818 (3R)-3-amino-7-(5-tert-butyl- 1,2,4-oxadiazol-3-yl)-8-fluoro- 5-[(4-fluorophenyl)methyl]- 1,1-dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 357 Diacylglycerol kinase alpha Homo sapiens 403 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703818&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573603 507747767 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457501 CC(C)(C)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(F)cc2)no1 InChI=1S/C22H22F2N4O4S/c1-22(2,3)21-26-19(27-32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 ZNXOUIHRDAABGR-UHFFFAOYSA-N 703818 (3R)-3-amino-7-(5-tert-butyl- 1,2,4-oxadiazol-3-yl)-8-fluoro- 5-[(4-fluorophenyl)methyl]- 1,1-dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 357 Diacylglycerol kinase zeta Homo sapiens 114 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703818&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573603 507747767 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457502 CC(C)(F)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(F)cc2)no1 InChI=1S/C21H19F3N4O4S/c1-21(2,24)20-26-18(27-32-20)13-7-16-17(8-14(13)23)33(30,31)10-15(25)19(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,25H2,1-2H3 RCHBXSFRJMWHJL-UHFFFAOYSA-N 703819 (3R)-3-amino-8-fluoro-7-[5-(1- fluoro-1-methyl-ethyl)-1,2,4- oxadiazol-3-yl]-5-[(4- fluorophenyl)methyl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 358 Diacylglycerol kinase alpha Homo sapiens 2699 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703819&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874320 507747768 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457503 CC(C)(F)c1nc(-c2cc3c(cc2F)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(F)cc2)no1 InChI=1S/C21H19F3N4O4S/c1-21(2,24)20-26-18(27-32-20)13-7-16-17(8-14(13)23)33(30,31)10-15(25)19(29)28(16)9-11-3-5-12(22)6-4-11/h3-8,15H,9-10,25H2,1-2H3 RCHBXSFRJMWHJL-UHFFFAOYSA-N 703819 (3R)-3-amino-8-fluoro-7-[5-(1- fluoro-1-methyl-ethyl)-1,2,4- oxadiazol-3-yl]-5-[(4- fluorophenyl)methyl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 358 Diacylglycerol kinase zeta Homo sapiens 122 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703819&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874320 507747768 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457504 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(Cl)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C22H23ClN4O4S/c1-22(2,3)21-26-25-19(31-21)14-6-9-18-17(10-14)27(11-13-4-7-15(23)8-5-13)20(28)16(24)12-32(18,29)30/h4-10,16H,11-12,24H2,1-3H3 NGQGMGCUBNHWNX-UHFFFAOYSA-N 703820 (3R)-3-amino-7-(5-tert-butyl- 1,3,4-oxadiazol-2-yl)-5-[(4- chlorophenyl)methyl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 361 Diacylglycerol kinase alpha Homo sapiens 876 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703820&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274340 507747769 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457505 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(Cl)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C22H23ClN4O4S/c1-22(2,3)21-26-25-19(31-21)14-6-9-18-17(10-14)27(11-13-4-7-15(23)8-5-13)20(28)16(24)12-32(18,29)30/h4-10,16H,11-12,24H2,1-3H3 NGQGMGCUBNHWNX-UHFFFAOYSA-N 703820 (3R)-3-amino-7-(5-tert-butyl- 1,3,4-oxadiazol-2-yl)-5-[(4- chlorophenyl)methyl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 361 Diacylglycerol kinase zeta Homo sapiens 933 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703820&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274340 507747769 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457506 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4CCCC(F)(F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClF2N4O4S/c25-17-6-3-14(4-7-17)12-31-19-10-15(5-8-20(19)36(33,34)13-18(28)23(31)32)21-29-30-22(35-21)16-2-1-9-24(26,27)11-16/h3-8,10,16,18H,1-2,9,11-13,28H2 UHWVTZSJAFQDLB-UHFFFAOYSA-N 703821 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (3,3-difluorocyclohexyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 373 Diacylglycerol kinase alpha Homo sapiens 1405 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703821&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573521 507747770 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457507 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4CCCC(F)(F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H23ClF2N4O4S/c25-17-6-3-14(4-7-17)12-31-19-10-15(5-8-20(19)36(33,34)13-18(28)23(31)32)21-29-30-22(35-21)16-2-1-9-24(26,27)11-16/h3-8,10,16,18H,1-2,9,11-13,28H2 UHWVTZSJAFQDLB-UHFFFAOYSA-N 703821 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (3,3-difluorocyclohexyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 373 Diacylglycerol kinase zeta Homo sapiens 644 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703821&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573521 507747770 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457508 COC1(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)CCC(F)(F)CC1 InChI=1S/C25H25ClF2N4O5S/c1-36-24(8-10-25(27,28)11-9-24)23-31-30-21(37-23)16-4-7-20-19(12-16)32(13-15-2-5-17(26)6-3-15)22(33)18(29)14-38(20,34)35/h2-7,12,18H,8-11,13-14,29H2,1H3 ZNIUBDIBUHVUOS-UHFFFAOYSA-N 703822 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (4,4-difluoro-1-methoxy- cyclohexyl)-1,3,4-oxadiazol-2- yl]-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 378 Diacylglycerol kinase alpha Homo sapiens 4057 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703822&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573529 507747771 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457509 COC1(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)CCC(F)(F)CC1 InChI=1S/C25H25ClF2N4O5S/c1-36-24(8-10-25(27,28)11-9-24)23-31-30-21(37-23)16-4-7-20-19(12-16)32(13-15-2-5-17(26)6-3-15)22(33)18(29)14-38(20,34)35/h2-7,12,18H,8-11,13-14,29H2,1H3 ZNIUBDIBUHVUOS-UHFFFAOYSA-N 703822 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (4,4-difluoro-1-methoxy- cyclohexyl)-1,3,4-oxadiazol-2- yl]-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 378 Diacylglycerol kinase zeta Homo sapiens 1436 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703822&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573529 507747771 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457510 Cc1cc(S(C)(=O)=O)ccc1-c1nnc(-c2ccc3c(c2)N(Cc2ccc(Cl)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H23ClN4O6S2/c1-15-11-19(38(2,33)34)8-9-20(15)25-30-29-24(37-25)17-5-10-23-22(12-17)31(13-16-3-6-18(27)7-4-16)26(32)21(28)14-39(23,35)36/h3-12,21H,13-14,28H2,1-2H3 WGILAIQTCZNXIM-UHFFFAOYSA-N 703823 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- methyl-4-methylsulfonyl- phenyl)-1,3,4-oxadiazol-2-yl]- 1,1-dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 379 Diacylglycerol kinase alpha Homo sapiens 42677 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703823&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573516 507747772 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457511 Cc1cc(S(C)(=O)=O)ccc1-c1nnc(-c2ccc3c(c2)N(Cc2ccc(Cl)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H23ClN4O6S2/c1-15-11-19(38(2,33)34)8-9-20(15)25-30-29-24(37-25)17-5-10-23-22(12-17)31(13-16-3-6-18(27)7-4-16)26(32)21(28)14-39(23,35)36/h3-12,21H,13-14,28H2,1-2H3 WGILAIQTCZNXIM-UHFFFAOYSA-N 703823 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- methyl-4-methylsulfonyl- phenyl)-1,3,4-oxadiazol-2-yl]- 1,1-dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 379 Diacylglycerol kinase zeta Homo sapiens 1305 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703823&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573516 507747772 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457512 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(C5CC5)CCCO4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C25H25ClN4O5S/c26-18-7-2-15(3-8-18)13-30-20-12-16(4-9-21(20)36(32,33)14-19(27)23(30)31)22-28-29-24(35-22)25(17-5-6-17)10-1-11-34-25/h2-4,7-9,12,17,19H,1,5-6,10-11,13-14,27H2 OKYFGQKXEKHIKY-UHFFFAOYSA-N 703824 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- cyclopropyltetrahydrofuran-2- yl)-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 381 Diacylglycerol kinase alpha Homo sapiens 3309 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703824&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874069 507747773 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457513 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(C5CC5)CCCO4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C25H25ClN4O5S/c26-18-7-2-15(3-8-18)13-30-20-12-16(4-9-21(20)36(32,33)14-19(27)23(30)31)22-28-29-24(35-22)25(17-5-6-17)10-1-11-34-25/h2-4,7-9,12,17,19H,1,5-6,10-11,13-14,27H2 OKYFGQKXEKHIKY-UHFFFAOYSA-N 703824 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- cyclopropyltetrahydrofuran-2- yl)-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 381 Diacylglycerol kinase zeta Homo sapiens 658 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703824&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874069 507747773 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457514 CN1CCCC(F)(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C24H25ClFN5O4S/c1-30-10-2-9-24(26,14-30)23-29-28-21(35-23)16-5-8-20-19(11-16)31(12-15-3-6-17(25)7-4-15)22(32)18(27)13-36(20,33)34/h3-8,11,18H,2,9-10,12-14,27H2,1H3 VEYIGDMPZHGJSJ-UHFFFAOYSA-N 703825 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(3-fluoro-1-methyl-3-piperidyl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 384 Diacylglycerol kinase alpha Homo sapiens 4579 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703825&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274362 507747774 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457515 CN1CCCC(F)(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C24H25ClFN5O4S/c1-30-10-2-9-24(26,14-30)23-29-28-21(35-23)16-5-8-20-19(11-16)31(12-15-3-6-17(25)7-4-15)22(32)18(27)13-36(20,33)34/h3-8,11,18H,2,9-10,12-14,27H2,1H3 VEYIGDMPZHGJSJ-UHFFFAOYSA-N 703825 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(3-fluoro-1-methyl-3-piperidyl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 384 Diacylglycerol kinase zeta Homo sapiens 2252 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703825&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274362 507747774 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457516 COCCN1CCCC(F)(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C26H29ClFN5O5S/c1-37-12-11-32-10-2-9-26(28,16-32)25-31-30-23(38-25)18-5-8-22-21(13-18)33(14-17-3-6-19(27)7-4-17)24(34)20(29)15-39(22,35)36/h3-8,13,20H,2,9-12,14-16,29H2,1H3 YIHPAYAIQNTJDY-UHFFFAOYSA-N 703826 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-[3- fluoro-1-(2-methoxyethyl)-3- piperidyl]-1,3,4-oxadiazol-2- yl]-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 386 Diacylglycerol kinase alpha Homo sapiens 3569 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703826&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774035 507747775 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457517 COCCN1CCCC(F)(c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C26H29ClFN5O5S/c1-37-12-11-32-10-2-9-26(28,16-32)25-31-30-23(38-25)18-5-8-22-21(13-18)33(14-17-3-6-19(27)7-4-17)24(34)20(29)15-39(22,35)36/h3-8,13,20H,2,9-12,14-16,29H2,1H3 YIHPAYAIQNTJDY-UHFFFAOYSA-N 703826 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-[3- fluoro-1-(2-methoxyethyl)-3- piperidyl]-1,3,4-oxadiazol-2- yl]-1,1-dioxo-2,3-dihydro- 1lambda6,5-benzothiazepin-4-one (*)::US20240368150, Example 386 Diacylglycerol kinase zeta Homo sapiens 778 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703826&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774035 507747775 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457518 Cc1ccc(-c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)cn1 InChI=1S/C24H20ClN5O4S/c1-14-2-5-17(11-27-14)23-29-28-22(34-23)16-6-9-21-20(10-16)30(12-15-3-7-18(25)8-4-15)24(31)19(26)13-35(21,32)33/h2-11,19H,12-13,26H2,1H3 QNELNKMYPJKADU-UHFFFAOYSA-N 703827 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(6-methyl-3-pyridyl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 390 Diacylglycerol kinase alpha Homo sapiens 38547 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703827&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874553 507747776 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457519 Cc1ccc(-c2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)cn1 InChI=1S/C24H20ClN5O4S/c1-14-2-5-17(11-27-14)23-29-28-22(34-23)16-6-9-21-20(10-16)30(12-15-3-7-18(25)8-4-15)24(31)19(26)13-35(21,32)33/h2-11,19H,12-13,26H2,1H3 QNELNKMYPJKADU-UHFFFAOYSA-N 703827 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(6-methyl-3-pyridyl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 390 Diacylglycerol kinase zeta Homo sapiens 2628 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703827&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874553 507747776 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457520 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(F)(F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H20ClF2N5O5S/c23-15-4-1-13(2-5-15)10-30-17-9-14(3-6-18(17)36(32,33)11-16(26)20(30)31)19-27-28-21(35-19)29-7-8-34-22(24,25)12-29/h1-6,9,16H,7-8,10-12,26H2 CGKGNQKNRDMWLN-UHFFFAOYSA-N 703828 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(2,2-difluoromorpholin-4-yl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 391 Diacylglycerol kinase alpha Homo sapiens 773 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703828&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874370 507747777 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457521 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(F)(F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H20ClF2N5O5S/c23-15-4-1-13(2-5-15)10-30-17-9-14(3-6-18(17)36(32,33)11-16(26)20(30)31)19-27-28-21(35-19)29-7-8-34-22(24,25)12-29/h1-6,9,16H,7-8,10-12,26H2 CGKGNQKNRDMWLN-UHFFFAOYSA-N 703828 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(2,2-difluoromorpholin-4-yl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 391 Diacylglycerol kinase zeta Homo sapiens 993 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703828&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874370 507747777 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457522 CC1(Nc2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)CC(F)(F)C1 InChI=1S/C23H22ClF2N5O4S/c1-22(11-23(25,26)12-22)28-21-30-29-19(35-21)14-4-7-18-17(8-14)31(9-13-2-5-15(24)6-3-13)20(32)16(27)10-36(18,33)34/h2-8,16H,9-12,27H2,1H3,(H,28,30) UMQVJEZLGDBFAU-UHFFFAOYSA-N 703829 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- [(3,3-difluoro-1-methyl- cyclobutyl)amino]-1,3,4- oxadiazol-2-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 406 Diacylglycerol kinase alpha Homo sapiens 5018 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703829&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573506 507747778 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457523 CC1(Nc2nnc(-c3ccc4c(c3)N(Cc3ccc(Cl)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)CC(F)(F)C1 InChI=1S/C23H22ClF2N5O4S/c1-22(11-23(25,26)12-22)28-21-30-29-19(35-21)14-4-7-18-17(8-14)31(9-13-2-5-15(24)6-3-13)20(32)16(27)10-36(18,33)34/h2-8,16H,9-12,27H2,1H3,(H,28,30) UMQVJEZLGDBFAU-UHFFFAOYSA-N 703829 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- [(3,3-difluoro-1-methyl- cyclobutyl)amino]-1,3,4- oxadiazol-2-yl]-1,1-dioxo-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one (*)::US20240368150, Example 406 Diacylglycerol kinase zeta Homo sapiens 13982 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703829&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573506 507747778 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457524 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4[C@@H]5CC[C@H]4COC5)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H24ClN5O5S/c25-16-4-1-14(2-5-16)10-29-20-9-15(3-8-21(20)36(32,33)13-19(26)23(29)31)22-27-28-24(35-22)30-17-6-7-18(30)12-34-11-17/h1-5,8-9,17-19H,6-7,10-13,26H2 WBGPGCUPXRPGPD-UHFFFAOYSA-N 703830 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- [(1R,5S)-3-oxa-8- azabicyclo[3.2.1]octan-8-yl]- 1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 407 Diacylglycerol kinase alpha Homo sapiens 1419 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703830&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164874398 507747779 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457525 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4[C@@H]5CC[C@H]4COC5)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H24ClN5O5S/c25-16-4-1-14(2-5-16)10-29-20-9-15(3-8-21(20)36(32,33)13-19(26)23(29)31)22-27-28-24(35-22)30-17-6-7-18(30)12-34-11-17/h1-5,8-9,17-19H,6-7,10-13,26H2 WBGPGCUPXRPGPD-UHFFFAOYSA-N 703830 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- [(1R,5S)-3-oxa-8- azabicyclo[3.2.1]octan-8-yl]- 1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 407 Diacylglycerol kinase zeta Homo sapiens 2661 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703830&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164874398 507747779 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457526 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC5CC54)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H22ClN5O5S/c24-15-4-1-13(2-5-15)11-29-18-9-14(3-6-20(18)35(31,32)12-16(25)22(29)30)21-26-27-23(34-21)28-7-8-33-19-10-17(19)28/h1-6,9,16-17,19H,7-8,10-12,25H2 WDBXVUSZTOPATA-UHFFFAOYSA-N 703831 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- oxa-5- azabicyclo[4.1.0]heptan-5-yl)- 1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 408 Diacylglycerol kinase alpha Homo sapiens 4767 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703831&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573621 507747780 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457527 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC5CC54)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H22ClN5O5S/c24-15-4-1-13(2-5-15)11-29-18-9-14(3-6-20(18)35(31,32)12-16(25)22(29)30)21-26-27-23(34-21)28-7-8-33-19-10-17(19)28/h1-6,9,16-17,19H,7-8,10-12,25H2 WDBXVUSZTOPATA-UHFFFAOYSA-N 703831 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(2- oxa-5- azabicyclo[4.1.0]heptan-5-yl)- 1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 408 Diacylglycerol kinase zeta Homo sapiens 881 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703831&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573621 507747780 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457528 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(C(F)F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H22ClF2N5O5S/c24-15-4-1-13(2-5-15)10-31-17-9-14(3-6-19(17)37(33,34)12-16(27)22(31)32)21-28-29-23(36-21)30-7-8-35-18(11-30)20(25)26/h1-6,9,16,18,20H,7-8,10-12,27H2 HJVFATFLCCRXIH-UHFFFAOYSA-N 703832 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-[2- (difluoromethyl)morpholin-4- yl]-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 409 Diacylglycerol kinase alpha Homo sapiens 2871 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703832&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573599 507747781 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457529 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(C(F)F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H22ClF2N5O5S/c24-15-4-1-13(2-5-15)10-31-17-9-14(3-6-19(17)37(33,34)12-16(27)22(31)32)21-28-29-23(36-21)30-7-8-35-18(11-30)20(25)26/h1-6,9,16,18,20H,7-8,10-12,27H2 HJVFATFLCCRXIH-UHFFFAOYSA-N 703832 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-[2- (difluoromethyl)morpholin-4- yl]-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 409 Diacylglycerol kinase zeta Homo sapiens 795 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703832&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573599 507747781 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457530 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC5(CC5)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H24ClN5O5S/c25-17-4-1-15(2-5-17)12-30-19-11-16(3-6-20(19)36(32,33)13-18(26)22(30)31)21-27-28-23(35-21)29-9-10-34-24(14-29)7-8-24/h1-6,11,18H,7-10,12-14,26H2 UOIWUAQGALINFN-UHFFFAOYSA-N 703833 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(4- oxa-7-azaspiro[2.5]octan-7- yl)-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 411 Diacylglycerol kinase alpha Homo sapiens 2089 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703833&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573572 507747782 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457531 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC5(CC5)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H24ClN5O5S/c25-17-4-1-15(2-5-17)12-30-19-11-16(3-6-20(19)36(32,33)13-18(26)22(30)31)21-27-28-23(35-21)29-9-10-34-24(14-29)7-8-24/h1-6,11,18H,7-10,12-14,26H2 UOIWUAQGALINFN-UHFFFAOYSA-N 703833 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5-(4- oxa-7-azaspiro[2.5]octan-7- yl)-1,3,4-oxadiazol-2-yl]-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 411 Diacylglycerol kinase zeta Homo sapiens 746 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703833&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573572 507747782 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457532 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(C(F)(F)F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClF3N5O5S/c24-15-4-1-13(2-5-15)10-32-17-9-14(3-6-18(17)38(34,35)12-16(28)21(32)33)20-29-30-22(37-20)31-7-8-36-19(11-31)23(25,26)27/h1-6,9,16,19H,7-8,10-12,28H2 HIANSQGFHZHCSY-UHFFFAOYSA-N 703834 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-1,1- dioxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,3,4-oxadiazol-2-yl]-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 412 Diacylglycerol kinase alpha Homo sapiens 2693 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703834&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573493 507747783 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457533 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(C(F)(F)F)C4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H21ClF3N5O5S/c24-15-4-1-13(2-5-15)10-32-17-9-14(3-6-18(17)38(34,35)12-16(28)21(32)33)20-29-30-22(37-20)31-7-8-36-19(11-31)23(25,26)27/h1-6,9,16,19H,7-8,10-12,28H2 HIANSQGFHZHCSY-UHFFFAOYSA-N 703834 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-1,1- dioxo-7-[5-[2- (trifluoromethyl)morpholin-4- yl]-1,3,4-oxadiazol-2-yl]-2,3- dihydro-1lambda6,5-benzothiazepin- 4-one::US20240368150, Example 412 Diacylglycerol kinase zeta Homo sapiens 484 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703834&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573493 507747783 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457534 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(F)(F)C4)o3)cc2N(Cc2ccc(Oc3ccccc3)cc2)C1=O InChI=1S/C28H25F2N5O6S/c29-28(30)17-34(12-13-39-28)27-33-32-25(41-27)19-8-11-24-23(14-19)35(26(36)22(31)16-42(24,37)38)15-18-6-9-21(10-7-18)40-20-4-2-1-3-5-20/h1-11,14,22H,12-13,15-17,31H2 AQDDYVCBTFBMQU-UHFFFAOYSA-N 703835 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(2,2-difluoromorpholin-4-yl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 413 Diacylglycerol kinase alpha Homo sapiens 1547 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703835&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873752 507747784 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457535 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(N4CCOC(F)(F)C4)o3)cc2N(Cc2ccc(Oc3ccccc3)cc2)C1=O InChI=1S/C28H25F2N5O6S/c29-28(30)17-34(12-13-39-28)27-33-32-25(41-27)19-8-11-24-23(14-19)35(26(36)22(31)16-42(24,37)38)15-18-6-9-21(10-7-18)40-20-4-2-1-3-5-20/h1-11,14,22H,12-13,15-17,31H2 AQDDYVCBTFBMQU-UHFFFAOYSA-N 703835 (3R)-3-amino-5-[(4-chlorophenyl)methyl]-7-[5-(2,2-difluoromorpholin-4-yl)-1,3,4-oxadiazol-2-yl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 413 Diacylglycerol kinase zeta Homo sapiens 1981 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703835&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873752 507747784 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457536 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(CC(F)(F)F)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O InChI=1S/C21H16F6N4O5S/c22-20(23,24)8-17-29-30-18(35-17)12-3-6-16-15(7-12)31(19(32)14(28)10-37(16,33)34)9-11-1-4-13(5-2-11)36-21(25,26)27/h1-7,14H,8-10,28H2 ZCHRCKIPYAZEFN-UHFFFAOYSA-N 703836 (3R)-3-amino-1,1-dioxo-7-[5- (2,2,2-trifluoroethyl)-1,3,4- oxadiazol-2-yl]-5-[[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 416 Diacylglycerol kinase alpha Homo sapiens 1448 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703836&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573562 507747785 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457537 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(CC(F)(F)F)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O InChI=1S/C21H16F6N4O5S/c22-20(23,24)8-17-29-30-18(35-17)12-3-6-16-15(7-12)31(19(32)14(28)10-37(16,33)34)9-11-1-4-13(5-2-11)36-21(25,26)27/h1-7,14H,8-10,28H2 ZCHRCKIPYAZEFN-UHFFFAOYSA-N 703836 (3R)-3-amino-1,1-dioxo-7-[5- (2,2,2-trifluoroethyl)-1,3,4- oxadiazol-2-yl]-5-[[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 416 Diacylglycerol kinase zeta Homo sapiens 1676 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703836&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573562 507747785 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457538 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(N)CCCCC4)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O InChI=1S/C25H26F3N5O5S/c26-25(27,28)38-17-7-4-15(5-8-17)13-33-19-12-16(6-9-20(19)39(35,36)14-18(29)22(33)34)21-31-32-23(37-21)24(30)10-2-1-3-11-24/h4-9,12,18H,1-3,10-11,13-14,29-30H2 RLLVENXDMISZTP-UHFFFAOYSA-N 703837 (3R)-3-amino-7-[5-(1- aminocyclohexyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo-5- [[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 417 Diacylglycerol kinase alpha Homo sapiens 6406 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703837&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573499 507747786 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457539 N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(N)CCCCC4)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O InChI=1S/C25H26F3N5O5S/c26-25(27,28)38-17-7-4-15(5-8-17)13-33-19-12-16(6-9-20(19)39(35,36)14-18(29)22(33)34)21-31-32-23(37-21)24(30)10-2-1-3-11-24/h4-9,12,18H,1-3,10-11,13-14,29-30H2 RLLVENXDMISZTP-UHFFFAOYSA-N 703837 (3R)-3-amino-7-[5-(1- aminocyclohexyl)-1,3,4- oxadiazol-2-yl]-1,1-dioxo-5- [[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 417 Diacylglycerol kinase zeta Homo sapiens 2114 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703837&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573499 507747786 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457540 CC(C)(C#N)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC(F)(F)F)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C23H20F3N5O5S/c1-22(2,12-27)21-30-29-19(35-21)14-5-8-18-17(9-14)31(20(32)16(28)11-37(18,33)34)10-13-3-6-15(7-4-13)36-23(24,25)26/h3-9,16H,10-11,28H2,1-2H3 WDLKNBWYSKPYEF-UHFFFAOYSA-N 703838 2-[5-[(3R)-3-amino-1,1,4- trioxo-5-[[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-7-yl]-1,3,4- oxadiazol-2-yl]-2-methyl- propanenitrile (*)::US20240368150, Example 420 Diacylglycerol kinase alpha Homo sapiens 806 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703838&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573555 507747787 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457541 CC(C)(C#N)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC(F)(F)F)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C23H20F3N5O5S/c1-22(2,12-27)21-30-29-19(35-21)14-5-8-18-17(9-14)31(20(32)16(28)11-37(18,33)34)10-13-3-6-15(7-4-13)36-23(24,25)26/h3-9,16H,10-11,28H2,1-2H3 WDLKNBWYSKPYEF-UHFFFAOYSA-N 703838 2-[5-[(3R)-3-amino-1,1,4- trioxo-5-[[4- (trifluoromethoxy)phenyl] methyl]-2,3-dihydro-1lambda6,5- benzothiazepin-7-yl]-1,3,4- oxadiazol-2-yl]-2-methyl- propanenitrile (*)::US20240368150, Example 420 Diacylglycerol kinase zeta Homo sapiens 454 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703838&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573555 507747787 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457542 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC4CCCC4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C27H32N4O5S/c1-27(2,3)26-30-29-24(36-26)18-10-13-23-22(14-18)31(25(32)21(28)16-37(23,33)34)15-17-8-11-20(12-9-17)35-19-6-4-5-7-19/h8-14,19,21H,4-7,15-16,28H2,1-3H3 BLVLFXSFBHAKJJ-UHFFFAOYSA-N 703839 (3R)-3-amino-7- (5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-5-[[4- (cyclopentoxy) phenyl]methyl]- 1,1-dioxo-2,3- dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 430 Diacylglycerol kinase alpha Homo sapiens 467 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703839&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573606 507747788 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457543 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC4CCCC4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C27H32N4O5S/c1-27(2,3)26-30-29-24(36-26)18-10-13-23-22(14-18)31(25(32)21(28)16-37(23,33)34)15-17-8-11-20(12-9-17)35-19-6-4-5-7-19/h8-14,19,21H,4-7,15-16,28H2,1-3H3 BLVLFXSFBHAKJJ-UHFFFAOYSA-N 703839 (3R)-3-amino-7- (5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-5-[[4- (cyclopentoxy) phenyl]methyl]- 1,1-dioxo-2,3- dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 430 Diacylglycerol kinase zeta Homo sapiens 594 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703839&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573606 507747788 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457544 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OCC4CC4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H30N4O5S/c1-26(2,3)25-29-28-23(35-25)18-8-11-22-21(12-18)30(24(31)20(27)15-36(22,32)33)13-16-6-9-19(10-7-16)34-14-17-4-5-17/h6-12,17,20H,4-5,13-15,27H2,1-3H3 UMJVOBJPSQHWAR-UHFFFAOYSA-N 703840 (3R)-3-amino-7- (5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-5-[[4- (cyclopropylmethoxy) phenyl]methyl]- 1,1-dioxo-2,3- dihydro-1lambda6,5- benzothiazepin- 4-one::US20240368150, Example 431 Diacylglycerol kinase alpha Homo sapiens 420 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703840 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703840&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573520 507747789 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457545 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OCC4CC4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H30N4O5S/c1-26(2,3)25-29-28-23(35-25)18-8-11-22-21(12-18)30(24(31)20(27)15-36(22,32)33)13-16-6-9-19(10-7-16)34-14-17-4-5-17/h6-12,17,20H,4-5,13-15,27H2,1-3H3 UMJVOBJPSQHWAR-UHFFFAOYSA-N 703840 (3R)-3-amino-7- (5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-5-[[4- (cyclopropylmethoxy) phenyl]methyl]- 1,1-dioxo-2,3- dihydro-1lambda6,5- benzothiazepin- 4-one::US20240368150, Example 431 Diacylglycerol kinase zeta Homo sapiens 683 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703840 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703840&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573520 507747789 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457546 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(C(C)(C)C#N)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H29N5O4S/c1-25(2,3)24-30-29-22(35-24)17-8-11-21-20(12-17)31(23(32)19(28)14-36(21,33)34)13-16-6-9-18(10-7-16)26(4,5)15-27/h6-12,19H,13-14,28H2,1-5H3 IQMLIPKVJAPORX-UHFFFAOYSA-N 703841 2-[4-[[(3R)-3- amino-7-(5-tert- butyl-1,3,4- oxadiazol-2-yl)- 1,1,4-trioxo-2,3- dihydro-1lambda6,5- benzothiazepin-5- yl]methyl]phenyl]- 2-methyl- propanenitrile::US20240368150, Example 437 Diacylglycerol kinase alpha Homo sapiens 528 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703841 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703841&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573549 507747790 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457547 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(C(C)(C)C#N)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C26H29N5O4S/c1-25(2,3)24-30-29-22(35-24)17-8-11-21-20(12-17)31(23(32)19(28)14-36(21,33)34)13-16-6-9-18(10-7-16)26(4,5)15-27/h6-12,19H,13-14,28H2,1-5H3 IQMLIPKVJAPORX-UHFFFAOYSA-N 703841 2-[4-[[(3R)-3- amino-7-(5-tert- butyl-1,3,4- oxadiazol-2-yl)- 1,1,4-trioxo-2,3- dihydro-1lambda6,5- benzothiazepin-5- yl]methyl]phenyl]- 2-methyl- propanenitrile::US20240368150, Example 437 Diacylglycerol kinase zeta Homo sapiens 3679 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703841 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703841&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573549 507747790 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457548 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(Oc4ccccc4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C28H28N4O5S/c1-28(2,3)27-31-30-25(37-27)19-11-14-24-23(15-19)32(26(33)22(29)17-38(24,34)35)16-18-9-12-21(13-10-18)36-20-7-5-4-6-8-20/h4-15,22H,16-17,29H2,1-3H3 RSUAGTYPTCSJGD-UHFFFAOYSA-N 703842 (3R)-3-amino- 7-(5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-1,1- dioxo-5-[(4- phenoxyphenyl) methyl]-2,3- dihydro-1lambda6,5- benzothiazepin- 4-one::US20240368150, Example 438 Diacylglycerol kinase alpha Homo sapiens 797 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703842 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703842&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573535 507747791 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457549 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(Oc4ccccc4)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C28H28N4O5S/c1-28(2,3)27-31-30-25(37-27)19-11-14-24-23(15-19)32(26(33)22(29)17-38(24,34)35)16-18-9-12-21(13-10-18)36-20-7-5-4-6-8-20/h4-15,22H,16-17,29H2,1-3H3 RSUAGTYPTCSJGD-UHFFFAOYSA-N 703842 (3R)-3-amino- 7-(5-tert-butyl- 1,3,4-oxadiazol- 2-yl)-1,1- dioxo-5-[(4- phenoxyphenyl) methyl]-2,3- dihydro-1lambda6,5- benzothiazepin- 4-one::US20240368150, Example 438 Diacylglycerol kinase zeta Homo sapiens 1345 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703842 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703842&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573535 507747791 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457550 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC(F)(F)C(F)F)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C24H24F4N4O5S/c1-23(2,3)22-31-30-19(36-22)14-6-9-18-17(10-14)32(20(33)16(29)12-38(18,34)35)11-13-4-7-15(8-5-13)37-24(27,28)21(25)26/h4-10,16,21H,11-12,29H2,1-3H3 OSZHDOQYGZDHKM-UHFFFAOYSA-N 703843 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1,1-dioxo-5-[[4-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 442 Diacylglycerol kinase alpha Homo sapiens 1387 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703843&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873923 507747792 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457551 CC(C)(C)c1nnc(-c2ccc3c(c2)N(Cc2ccc(OC(F)(F)C(F)F)cc2)C(=O)[C@@H](N)CS3(=O)=O)o1 InChI=1S/C24H24F4N4O5S/c1-23(2,3)22-31-30-19(36-22)14-6-9-18-17(10-14)32(20(33)16(29)12-38(18,34)35)11-13-4-7-15(8-5-13)37-24(27,28)21(25)26/h4-10,16,21H,11-12,29H2,1-3H3 OSZHDOQYGZDHKM-UHFFFAOYSA-N 703843 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1,1-dioxo-5-[[4-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 442 Diacylglycerol kinase zeta Homo sapiens 285 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703843&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873923 507747792 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457552 COC(=O)N1CCC(c2nnc(-c3ccc4c(c3)N(Cc3ccc(OC5CCCC5)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C29H33N5O7S/c1-39-29(36)33-13-12-20(16-33)27-32-31-26(41-27)19-8-11-25-24(14-19)34(28(35)23(30)17-42(25,37)38)15-18-6-9-22(10-7-18)40-21-4-2-3-5-21/h6-11,14,20-21,23H,2-5,12-13,15-17,30H2,1H3 QWWJZQOPKHGVKB-UHFFFAOYSA-N 703844 methyl 3-[5-[(3R)-3-amino-5-[[4-(cyclopentoxy)phenyl]methyl]-1,1,4-trioxo-2,3-dihydro-1λ6,5-benzothiazepin-7-yl]-1,3,4-oxadiazol-2-yl]pyrrolidine-1-carboxylate::US20240368150, Example 444 Diacylglycerol kinase alpha Homo sapiens 6112 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703844&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274384 507747793 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457553 COC(=O)N1CCC(c2nnc(-c3ccc4c(c3)N(Cc3ccc(OC5CCCC5)cc3)C(=O)[C@@H](N)CS4(=O)=O)o2)C1 InChI=1S/C29H33N5O7S/c1-39-29(36)33-13-12-20(16-33)27-32-31-26(41-27)19-8-11-25-24(14-19)34(28(35)23(30)17-42(25,37)38)15-18-6-9-22(10-7-18)40-21-4-2-3-5-21/h6-11,14,20-21,23H,2-5,12-13,15-17,30H2,1H3 QWWJZQOPKHGVKB-UHFFFAOYSA-N 703844 methyl 3-[5-[(3R)-3-amino-5-[[4-(cyclopentoxy)phenyl]methyl]-1,1,4-trioxo-2,3-dihydro-1λ6,5-benzothiazepin-7-yl]-1,3,4-oxadiazol-2-yl]pyrrolidine-1-carboxylate::US20240368150, Example 444 Diacylglycerol kinase zeta Homo sapiens 1906 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703844&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274384 507747793 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457554 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O4S/c1-22(2,3)21-30-29-19(34-21)14-8-17-18(9-15(14)24)36(33)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)35-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VVCQPIKPJDMZLC-UHFFFAOYSA-N 703845 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimer A)::US20240368150, Example 452 Diacylglycerol kinase alpha Homo sapiens 340 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703845&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 164873827 507747794 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457555 CC(C)(C)c1nnc(-c2cc3c(cc2F)S(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H22F4N4O4S/c1-22(2,3)21-30-29-19(34-21)14-8-17-18(9-15(14)24)36(33)11-16(28)20(32)31(17)10-12-4-6-13(7-5-12)35-23(25,26)27/h4-9,16H,10-11,28H2,1-3H3 VVCQPIKPJDMZLC-UHFFFAOYSA-N 703845 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ4,5-benzothiazepin-4-one (Epimer A)::US20240368150, Example 452 Diacylglycerol kinase zeta Homo sapiens 400 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703845&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 164873827 507747794 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457556 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC4CCC4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O4S/c23-13-6-4-12(5-7-13)10-29-18-8-15(20-27-28-22(33-20)26-14-2-1-3-14)16(24)9-19(18)34(31,32)11-17(25)21(29)30/h4-9,14,17H,1-3,10-11,25H2,(H,26,28) AKZPXCQWYQJACI-UHFFFAOYSA-N 703846 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (cyclobutylamino)-1,3,4- oxadiazol-2-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 459 Diacylglycerol kinase alpha Homo sapiens 625 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703846&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171573488 507747795 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457557 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC4CCC4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C22H21ClFN5O4S/c23-13-6-4-12(5-7-13)10-29-18-8-15(20-27-28-22(33-20)26-14-2-1-3-14)16(24)9-19(18)34(31,32)11-17(25)21(29)30/h4-9,14,17H,1-3,10-11,25H2,(H,26,28) AKZPXCQWYQJACI-UHFFFAOYSA-N 703846 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (cyclobutylamino)-1,3,4- oxadiazol-2-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6,5- benzothiazepin-4-one (*)::US20240368150, Example 459 Diacylglycerol kinase zeta Homo sapiens 632 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703846&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171573488 507747795 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457558 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC4CCCCC4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H25ClFN5O4S/c25-15-8-6-14(7-9-15)12-31-20-10-17(18(26)11-21(20)36(33,34)13-19(27)23(31)32)22-29-30-24(35-22)28-16-4-2-1-3-5-16/h6-11,16,19H,1-5,12-13,27H2,(H,28,30) AIKIXSXYDLKAEZ-UHFFFAOYSA-N 703847 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (cyclohexylamino)-1,3,4- oxadiazol-2-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-lambda6,5- benzothiazepin-4-one (**)::US20240368150, Example 466 Diacylglycerol kinase alpha Homo sapiens 2091 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703847&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774076 507747796 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457559 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC4CCCCC4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C24H25ClFN5O4S/c25-15-8-6-14(7-9-15)12-31-20-10-17(18(26)11-21(20)36(33,34)13-19(27)23(31)32)22-29-30-24(35-22)28-16-4-2-1-3-5-16/h6-11,16,19H,1-5,12-13,27H2,(H,28,30) AIKIXSXYDLKAEZ-UHFFFAOYSA-N 703847 (3R)-3-amino-5-[(4- chlorophenyl)methyl]-7-[5- (cyclohexylamino)-1,3,4- oxadiazol-2-yl]-8-fluoro-1,1- dioxo-2,3-dihydro-lambda6,5- benzothiazepin-4-one (**)::US20240368150, Example 466 Diacylglycerol kinase zeta Homo sapiens 1032 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703847&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774076 507747796 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457560 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC45CC(Cl)(C4)C5)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20Cl2FN5O4S/c24-13-3-1-12(2-4-13)7-31-17-5-14(15(26)6-18(17)36(33,34)8-16(27)20(31)32)19-29-30-21(35-19)28-23-9-22(25,10-23)11-23/h1-6,16H,7-11,27H2,(H,28,30) CMMHYCFVCXIROX-UHFFFAOYSA-N 703848 (3R)-3-amino-7-[5-[(3-chloro-1- bicyclo[1.1.1]pentanyl)amino]- 1,3,4-oxadiazol-2-yl]-5-[(4- chlorophenyl)methyl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6.5- benzothiazepin-4-one (*)::US20240368150, Example 500 Diacylglycerol kinase alpha Homo sapiens 1734 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703848&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774021 507747797 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457561 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3nnc(NC45CC(Cl)(C4)C5)o3)cc2N(Cc2ccc(Cl)cc2)C1=O InChI=1S/C23H20Cl2FN5O4S/c24-13-3-1-12(2-4-13)7-31-17-5-14(15(26)6-18(17)36(33,34)8-16(27)20(31)32)19-29-30-21(35-19)28-23-9-22(25,10-23)11-23/h1-6,16H,7-11,27H2,(H,28,30) CMMHYCFVCXIROX-UHFFFAOYSA-N 703848 (3R)-3-amino-7-[5-[(3-chloro-1- bicyclo[1.1.1]pentanyl)amino]- 1,3,4-oxadiazol-2-yl]-5-[(4- chlorophenyl)methyl]-8-fluoro-1,1- dioxo-2,3-dihydro-1lambda6.5- benzothiazepin-4-one (*)::US20240368150, Example 500 Diacylglycerol kinase zeta Homo sapiens 1827 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703848&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774021 507747797 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457562 CC(C)(C)c1nnc(-c2cc3c(cc2F)[S@](=N)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H23F4N5O4S/c1-22(2,3)21-31-30-19(35-21)14-8-17-18(9-15(14)24)37(29,34)11-16(28)20(33)32(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16,29H,10-11,28H2,1-3H3 CIUYKJFWLABQJG-UHFFFAOYSA-N 703849 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-imino-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 517 Diacylglycerol kinase alpha Homo sapiens 272 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703849&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 172879044 507747798 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457563 CC(C)(C)c1nnc(-c2cc3c(cc2F)[S@](=N)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H23F4N5O4S/c1-22(2,3)21-31-30-19(35-21)14-8-17-18(9-15(14)24)37(29,34)11-16(28)20(33)32(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16,29H,10-11,28H2,1-3H3 CIUYKJFWLABQJG-UHFFFAOYSA-N 703849 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-imino-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 517 Diacylglycerol kinase zeta Homo sapiens 316 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703849&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 172879044 507747798 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457564 CC(C)(C)c1nnc(-c2cc3c(cc2F)[S@@](=N)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H23F4N5O4S/c1-22(2,3)21-31-30-19(35-21)14-8-17-18(9-15(14)24)37(29,34)11-16(28)20(33)32(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16,29H,10-11,28H2,1-3H3 CIUYKJFWLABQJG-UHFFFAOYSA-N 703850 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-imino-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 518 Diacylglycerol kinase alpha Homo sapiens 442 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703850&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 172879045 507747799 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457565 CC(C)(C)c1nnc(-c2cc3c(cc2F)[S@@](=N)(=O)C[C@H](N)C(=O)N3Cc2ccc(OC(F)(F)F)cc2)o1 InChI=1S/C23H23F4N5O4S/c1-22(2,3)21-31-30-19(35-21)14-8-17-18(9-15(14)24)37(29,34)11-16(28)20(33)32(17)10-12-4-6-13(7-5-12)36-23(25,26)27/h4-9,16,29H,10-11,28H2,1-3H3 CIUYKJFWLABQJG-UHFFFAOYSA-N 703850 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-fluoro-1-imino-1-oxo-5-[[4-(trifluoromethoxy)phenyl]methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 518 Diacylglycerol kinase zeta Homo sapiens 639 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703850&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 172879045 507747799 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457566 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(C4(CO)CCCO4)n3)cc2N(Cc2ccc(Oc3ccccc3)cc2)C1=O InChI=1S/C29H27FN4O7S/c30-22-14-25-24(13-21(22)26-32-28(41-33-26)29(17-35)11-4-12-39-29)34(27(36)23(31)16-42(25,37)38)15-18-7-9-20(10-8-18)40-19-5-2-1-3-6-19/h1-3,5-10,13-14,23,35H,4,11-12,15-17,31H2 FKRHUQWPQOJOKU-UHFFFAOYSA-N 703851 (3R)-3-amino-8-fluoro-7-[5-[2-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-oxadiazol-3-yl]-1,1-dioxo-5-[(4-phenoxyphenyl)methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 521 Diacylglycerol kinase alpha Homo sapiens 3002 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703851&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274339 507747800 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457567 N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(C4(CO)CCCO4)n3)cc2N(Cc2ccc(Oc3ccccc3)cc2)C1=O InChI=1S/C29H27FN4O7S/c30-22-14-25-24(13-21(22)26-32-28(41-33-26)29(17-35)11-4-12-39-29)34(27(36)23(31)16-42(25,37)38)15-18-7-9-20(10-8-18)40-19-5-2-1-3-6-19/h1-3,5-10,13-14,23,35H,4,11-12,15-17,31H2 FKRHUQWPQOJOKU-UHFFFAOYSA-N 703851 (3R)-3-amino-8-fluoro-7-[5-[2-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-oxadiazol-3-yl]-1,1-dioxo-5-[(4-phenoxyphenyl)methyl]-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 521 Diacylglycerol kinase zeta Homo sapiens 338 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703851&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274339 507747800 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457568 CN1CCCC(F)(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Oc4ccccc4)cc3)no2)C1 InChI=1S/C30H29F2N5O5S/c1-36-13-5-12-30(32,18-36)29-34-27(35-42-29)22-14-25-26(15-23(22)31)43(39,40)17-24(33)28(38)37(25)16-19-8-10-21(11-9-19)41-20-6-3-2-4-7-20/h2-4,6-11,14-15,24H,5,12-13,16-18,33H2,1H3 FOMNSFFXNUHODB-UHFFFAOYSA-N 703852 (3R)-3-amino-8-fluoro- 7-[5-(3-fluoro-1-methyl- 3-piperidyl)-1,2,4- oxadiazol-3-yl]-1,1- dioxo-5-[(4- phenoxyphenyl)methyl]- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 522 Diacylglycerol kinase alpha Homo sapiens 4070 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703852&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 171774006 507747801 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457569 CN1CCCC(F)(c2nc(-c3cc4c(cc3F)S(=O)(=O)C[C@H](N)C(=O)N4Cc3ccc(Oc4ccccc4)cc3)no2)C1 InChI=1S/C30H29F2N5O5S/c1-36-13-5-12-30(32,18-36)29-34-27(35-42-29)22-14-25-26(15-23(22)31)43(39,40)17-24(33)28(38)37(25)16-19-8-10-21(11-9-19)41-20-6-3-2-4-7-20/h2-4,6-11,14-15,24H,5,12-13,16-18,33H2,1H3 FOMNSFFXNUHODB-UHFFFAOYSA-N 703852 (3R)-3-amino-8-fluoro- 7-[5-(3-fluoro-1-methyl- 3-piperidyl)-1,2,4- oxadiazol-3-yl]-1,1- dioxo-5-[(4- phenoxyphenyl)methyl]- 2,3-dihydro-1lambda6,5- benzothiazepin-4-one::US20240368150, Example 522 Diacylglycerol kinase zeta Homo sapiens 529 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703852&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 171774006 507747801 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9 1457570 CC(C)(C)c1nnc(-c2cc3c(cc2Cl)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C22H22Cl2N4O4S/c1-22(2,3)21-27-26-19(32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 SQBGFZRFBKTMPI-UHFFFAOYSA-N 703853 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-chloro-5-[(4-chlorophenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 523 Diacylglycerol kinase alpha Homo sapiens 1294 US Patent 10.7270/Q21N85N3 aid2060557 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000713&target=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703853&enzyme=Diacylglycerol+kinase+alpha&column=ki&startPg=0&Increment=50&submit=Search 169274453 507747802 1 MAKERGLISPSDFAQLQKYMEYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFSLLEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLEMTLKDDGQHMWRPKRFPRPVYCNLCESSIGLGKQGLSCNLCKYTVHDQCAMKALPCEVSTYAKSRKDIGVQSHVWVRGGCESGRCDRCQKKIRIYHSLTGLHCVWCHLEIHDDCLQAVGHECDCGLLRDHILPPSSIYPSVLASGPDRKNSKTSQKTMDDLNLSTSEALRIDPVPNTHPLLVFVNPKSGGKQGQRVLWKFQYILNPRQVFNLLKDGPEIGLRLFKDVPDSRILVCGGDGTVGWILETIDKANLPVLPPVAVLPLGTGNDLARCLRWGGGYEGQNLAKILKDLEMSKVVHMDRWSVEVIPQQTEEKSDPVPFQIINNYFSIGVDASIAHRFHIMREKYPEKFNSRMKNKLWYFEFATSESIFSTCKKLEESLTVEICGKPLDLSNLSLEGIAVLNIPSMHGGSNLWGDTRRPHGDIYGINQALGATAKVITDPDILKTCVPDLSDKRLEVVGLEGAIEMGQIYTKLKNAGRRLAKCSEITFHTTKTLPMQIDGEPWMQTPCTIKITHKNQMPMLMGPPPRSTNFFGFLS Diacylglycerol kinase alpha DGKA_HUMAN P23743 O75481 O75482 O75483 O95217 Q3ZE25 Q8IZ56 Q8N5Q2 1457571 CC(C)(C)c1nnc(-c2cc3c(cc2Cl)S(=O)(=O)C[C@H](N)C(=O)N3Cc2ccc(Cl)cc2)o1 InChI=1S/C22H22Cl2N4O4S/c1-22(2,3)21-27-26-19(32-21)14-8-17-18(9-15(14)24)33(30,31)11-16(25)20(29)28(17)10-12-4-6-13(23)7-5-12/h4-9,16H,10-11,25H2,1-3H3 SQBGFZRFBKTMPI-UHFFFAOYSA-N 703853 (3R)-3-amino-7-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-8-chloro-5-[(4-chlorophenyl)methyl]-1,1-dioxo-2,3-dihydro-1λ6,5-benzothiazepin-4-one::US20240368150, Example 523 Diacylglycerol kinase zeta Homo sapiens 1512 US Patent 10.7270/Q21N85N3 US20240368150 BRITSCHGI, A; HUTTER, R; KUEHNE, H; KUHN, B; LUEBBERS, T; MARTIN, LJ; MUELLER, BJ; WICHMANN, J; BRANDSTAETTER, M 11/7/2024 3/14/2025 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=703853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50007393&target=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=703853&enzyme=Diacylglycerol+kinase+zeta&column=ki&startPg=0&Increment=50&submit=Search 169274453 507747802 1 METFFRRHFRGKVPGPGEGQQRPSSVGLPTGKARRRSPAGQASSSLAQRRRSSAQLQGCLLSCGVRAQGSSRRRSSTVPPSCNPRFIVDKVLTPQPTTVGAQLLGAPLLLTGLVGMNEEEGVQEDVVAEASSAIQPGTKTPGPPPPRGAQPLLPLPRYLRRASSHLLPADAVYDHALWGLHGYYRRLSQRRPSGQHPGPGGRRASGTTAGTMLPTRVRPLSRRRQVALRRKAAGPQAWSALLAKAITKSGLQHLAPPPPTPGAPCSESERQIRSTVDWSESATYGEHIWFETNVSGDFCYVGEQYCVARMLKSVSRRKCAACKIVVHTPCIEQLEKINFRCKPSFRESGSRNVREPTFVRHHWVHRRRQDGKCRHCGKGFQQKFTFHSKEIVAISCSWCKQAYHSKVSCFMLQQIEEPCSLGVHAAVVIPPTWILRARRPQNTLKASKKKKRASFKRKSSKKGPEEGRWRPFIIRPTPSPLMKPLLVFVNPKSGGNQGAKIIQSFLWYLNPRQVFDLSQGGPKEALEMYRKVHNLRILACGGDGTVGWILSTLDQLRLKPPPPVAILPLGTGNDLARTLNWGGGYTDEPVSKILSHVEEGNVVQLDRWDLHAEPNPEAGPEDRDEGATDRLPLDVFNNYFSLGFDAHVTLEFHESREANPEKFNSRFRNKMFYAGTAFSDFLMGSSKDLAKHIRVVCDGMDLTPKIQDLKPQCVVFLNIPRYCAGTMPWGHPGEHHDFEPQRHDDGYLEVIGFTMTSLAALQVGGHGERLTQCREVVLTTSKAIPVQVDGEPCKLAASRIRIALRNQATMVQKAKRRSAAPLHSDQQPVPEQLRIQVSRVSMHDYEALHYDKEQLKEASVPLGTVVVPGDSDLELCRAHIERLQQEPDGAGAKSPTCQKLSPKWCFLDATTASRFYRIDRAQEHLNYVTEIAQDEIYILDPELLGASARPDLPTPTSPLPTSPCSPTPRSLQGDAAPPQGEELIEAAKRNDFCKLQELHRAGGDLMHRDEQSRTLLHHAVSTGSKDVVRYLLDHAPPEILDAVEENGETCLHQAAALGQRTICHYIVEAGASLMKTDQQGDTPRQRAEKAQDTELAAYLENRQHYQMIQREDQETAV Diacylglycerol kinase zeta DGKZ_HUMAN Q13574 B7Z2M9 B7Z6M3 E9PPW4 F6UCU9 G3V0F6 J3KNJ6 O00542 Q6ZVG7 Q8IVW9